Infective dermatitis

L12_INFECT_DERM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L30.3 Cause of death: ICD-10 — L30.3 2 out of 7 registries used, show all original rules.	5634
4. Check minimum number of events None	5634
5. Include endpoints None	5634
6. Filter based on genotype QC (FinnGen only)	5070

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L30
Name in latin: Dermatitis infectiosa

NAME	L12_INFECT_DERM
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L303
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L303
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infective dermatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38784	18479	20130
Only index persons	35334	17298	18036
Unadjusted period prevalence (%)
Whole population	0.54	0.53	0.56
Only index persons	0.66	0.64	0.69
Median age at first event (years)
Whole population	52.86	51.94	53.63
Only index persons	52.28	51.57	52.96

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5070	2640	2430
Unadjusted period prevalence (%)	1.02	0.94	1.11
Median age at first event (years)	55.43	51.77	59.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5237: Matched controls
52370

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E000007, ,

ATC

6.8

315.5

521

833

L30.0

ICD-10 Finland

Nummular dermatitis

22.5

307.7

908

483

E000003, ,

ATC

10.2

307.7

589

645

L30.9

ICD-10 Finland

Dermatitis, unspecified

11.4

307.7

2636

4265

E000001, ,

ATC

7.1

307.7

2191

4828

D07AC01

ATC

betamethasone; topical

8.9

307.7

3705

11226

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

307.7

556

L20.0

ICD-10 Finland

Besnier prurigo

+∞

307.7

911

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

45.2

307.7

374

D07AB08

ATC

desonide; topical

7.4

307.7

1221

2079

D07AA02

ATC

hydrocortisone; topical

4.2

307.7

1100

3113

L30.3

ICD-10 Finland

Infective dermatitis

4503599627370496.0

307.7

5236

237

D07AC13

ATC

mometasone; topical

6.4

307.7

2847

8248

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

11.3

307.7

1299

1489

TQW80

NOMESCO Finland

Local dermatologic skincare

23.3

307.7

582

280

D07XC01

ATC

betamethasone; topical

4.4

307.7

1097

2994

XQ800

NOMESCO Finland

Prick test

6.1

307.7

655

1203

E000006, ,

ATC

6.5

307.7

714

1239

E000002, ,

ATC

6.9

307.7

1209

2176

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.1

307.7

1063

1805

E0000UV, ,

ATC

8.4

307.7

3854

13002

D02AE01

ATC

carbamide; topical

6.5

307.7

676

1174

D07BA04

ATC

hydrocortisone and antiseptics; topical

5.9

307.7

1041

2110

D07BC01

ATC

betamethasone and antiseptics; topical

8.0

307.7

1625

2780

D09AB01

ATC

zinc bandage without supplements; topical

33.8

307.7

571

189

D07AD01

ATC

clobetasol; topical

7.3

307.7

2041

4192

D07CC01

ATC

betamethasone and antibiotics; topical

5.3

307.7

1313

3114

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

7.6

307.7

1697

3107

D07AB02

ATC

hydrocortisone butyrate; topical

4.3

307.7

2420

8670

XQ802

NOMESCO Finland

Epicutan test

59.5

307.7

859

172

H02AB06

ATC

prednisolone; systemic

2.9

301.7

3109

17554

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

128.7

297.1

150

L28.1

ICD-10 Finland

Prurigo nodularis

99.1

297.1

154

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

136.4

264.7

133

L30.8

ICD-10 Finland

Other specified dermatitis

10.2

260.0

299

309

D02AX

ATC

Other emollients and protectives

9.2

256.1

318

364

L20

ICD-10 Finland

Atopic dermatitis

+∞

239.4

228

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

81.3

238.9

127

D05BB02

ATC

acitretin; oral

9.1

235.1

295

342

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

36.5

227.7

142

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.8

225.1

1567

7001

A46

ICD-10 Finland

Erysipelas

3.1

218.7

1142

4360

XQ848

NOMESCO Finland

Dermatological photography

7.4

217.8

325

463

R06AE07

ATC

cetirizine; oral

2.4

212.7

2621

15256

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

202.4

193

E000004, ,

ATC

10.0

202.1

235

246

L28.0

ICD-10 Finland

Lichen simplex chronicus

33.6

200.6

128

S87

ICPC

Dermatitis/atopic eczema

8.6

197.5

258

314

D07AC14

ATC

methylprednisolone aceponate; topical

5.3

193.8

408

817

L40.0

ICD-10 Finland

Psoriasis vulgaris

5.2

191.2

411

838

N05BB01

ATC

hydroxyzine; systemic

4.4

185.0

492

1195

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

10.6

182.8

203

199

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

65.9

176.7

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

359.0

174.4

175

J01DB01

ATC

cefalexin; oral

3.1

163.5

4611

36783

R06AX27

ATC

desloratadine; oral

2.3

156.7

1694

9035

J01FF01

ATC

clindamycin; systemic

2.3

150.9

1675

9008

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

33.7

150.6

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

6.8

136.0

218

334

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

38.3

134.9

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

132.9

127

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

197.9

130.3

135

R06AE09

ATC

levocetirizine; oral

2.6

129.9

881

3774

D05AX52

ATC

calcipotriol, combinations; topical

3.8

129.4

425

1197

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.7

126.3

802

3323

J01DA01

ATC

[U] cefalexin

2.0

121.4

3347

24552

D11AH01

ATC

tacrolimus; topical

182.9

120.0

125

L04AX03

ATC

methotrexate; systemic

2.8

115.5

662

2597

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.4

105.4

816

3693

D07AB01

ATC

clobetasone; topical

4.7

101.3

240

528

D07XB05

ATC

dexamethasone; topical

5.3

100.4

205

397

S29

ICPC

Skin symptom/complaint other

2.1

94.6

1179

6453

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

92.3

794

3750

L29.9

ICD-10 Finland

Pruritus, unspecified

5.4

90.6

182

347

SPAT1263

SPAT

Sampling

1.8

86.7

2234

15401

S97

ICPC

Chronic ulcer skin

2.9

85.3

430

1566

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

16.0

83.0

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

82.5

B35.3

ICD-10 Finland

Tinea pedis

3.2

81.8

336

1087

L04AD01

ATC

ciclosporin; systemic

5.7

81.5

153

274

J01AA04

ATC

lymecycline; systemic

2.2

79.8

746

3632

L50.3

ICD-10 Finland

Dermatographic urticaria

6.2

78.8

135

221

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

9.5

78.7

SPAT1301

SPAT

No procedures

1.8

77.7

1662

10763

J01DA09

ATC

[U] cefadroxil

1.9

77.5

1414

8724

S76

ICPC

Skin infection other

3.0

77.4

374

1329

L08.0

ICD-10 Finland

Pyoderma

8.3

73.5

119

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.1

71.7

306

1012

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

71.3

323

1106

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

71.0

D06AX01

ATC

fusidic acid; topical

2.4

69.5

535

2391

J01AA07

ATC

tetracycline; systemic

2.1

69.4

781

4073

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.6

68.8

168

378

R06AX22

ATC

ebastine; oral

2.0

68.7

879

4800

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

68.3

2488

18463

S21

ICPC

Skin texture symptom/complaint

2.0

66.7

852

4646

SPAT1260

SPAT

Consultation of another employee

1.9

65.7

937

5304

C03CA01

ATC

furosemide; systemic

1.7

65.2

1526

10041

D11AX14

ATC

[U] tacrolimus

+∞

64.7

J01CF05

ATC

flucloxacillin; systemic

2.5

63.9

441

1874

S18

ICPC

Laceration/cut

1.6

63.7

2461

18420

D07CB01

ATC

triamcinolone and antibiotics; topical

4.7

62.5

148

325

S02

ICPC

Pruritus

3.5

62.0

222

658

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

10.8

61.0

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.2

61.0

164

398

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

60.8

255

834

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.0

59.5

105

177

SPAT1312

SPAT

General health counselling

1.7

58.1

1605

10973

H02AB04

ATC

methylprednisolone; systemic

2.0

57.8

743

4046

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

295.2

57.4

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

5.0

56.4

123

252

B86

ICD-10 Finland

Scabies

3.8

56.3

177

481

S06

ICPC

Rash localized

2.6

56.1

334

1321

R03AC02

ATC

salbutamol; inhalant

1.6

55.8

2727

21332

J04BA02

ATC

dapsone; oral

10.8

55.7

SPAT1310

SPAT

Counselling related to known health issue

1.6

55.1

1584

10909

D05AX02

ATC

calcipotriol; topical

3.1

55.0

237

787

D11AH04

ATC

alitretinoin; oral

279.2

54.3

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

53.4

405

1793

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

4.7

53.1

124

269

L04AA01

ATC

[U] ciclosporin

5.5

53.0

102

187

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

52.6

963

5856

S01

ICPC

Pain/tenderness of skin

2.7

51.2

297

1158

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

51.2

656

3558

S88

ICPC

Dermatitis contact/allergic

4.2

50.9

138

337

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

50.8

484

2354

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

50.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

50.0

1444

9913

L29.8

ICD-10 Finland

Other pruritus

5.9

50.0

155

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

49.9

1938

14267

UJF32

NOMESCO Finland

Coloscopy

1.7

49.5

1307

8768

D01AC02

ATC

miconazole; topical

2.3

48.5

411

1906

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

48.3

1489

10369

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

48.0

623

3389

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

47.7

473

2335

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

46.9

L21.0

ICD-10 Finland

Seborrhoea capitis

7.6

46.6

WZC30

NOMESCO Finland

Teaching

1.8

46.4

892

5483

S99

ICPC

Skin disease other

3.7

45.8

148

410

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

45.7

137

360

L04AX01

ATC

azathioprine; systemic

2.8

45.6

232

845

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

45.1

569

3062

L40.9

ICD-10 Finland

Psoriasis, unspecified

4.3

44.9

116

273

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

44.3

942

5946

SPAT1153

SPAT

Removal of sutures

1.6

44.3

1535

10943

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

44.2

380

1770

D01AE15

ATC

terbinafine; topical

2.2

43.9

396

1882

D11AH02

ATC

pimecrolimus; topical

431.2

43.2

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

151.3

42.8

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

42.8

509

2683

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

42.7

1292

8910

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

42.3

2047

15648

N07BA03

ATC

varenicline; oral

2.5

41.6

282

1185

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.5

40.8

101

230

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

7.7

40.7

R06AX13

ATC

loratadine; oral

1.8

40.1

693

4117

L30.4

ICD-10 Finland

Erythema intertrigo

5.0

39.6

176

R06.0

ICD-10 Finland

Dyspnoea

1.6

39.1

1321

9315

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

38.8

562

3160

L85.3

ICD-10 Finland

Xerosis cutis

5.3

38.0

148

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

38.0

1976

15233

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

196.4

37.8

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

37.7

1239

8670

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.8

37.7

195

717

L30

ICD-10 Finland

Other dermatitis

3.4

37.5

136

407

134

Kela drug reimbursment

General erythroderma

10.1

37.1

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.7

37.0

119

329

SPAT1262

SPAT

Handing over of treatment supplies

1.6

35.9

864

5605

M79.6

ICD-10 Finland

Pain in limb

1.5

35.8

2123

16728

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

35.3

1515

11199

R02

ICPC

Shortness of breath/dyspnoea

1.7

35.2

671

4090

L73.8

ICD-10 Finland

Other specified follicular disorders

5.0

35.2

151

N02BE01

ATC

paracetamol; systemic, rectal

1.7

35.1

4524

41426

L23

ICD-10 Finland

Allergic contact dermatitis

7.6

34.8

D11AH05

ATC

dupilumab; topical

14.0

34.8

R60.0

ICD-10 Finland

Localized oedema

1.8

34.8

624

3738

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

34.3

209

835

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

34.1

668

4099

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

34.0

648

3947

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

33.8

643

3915

J01DB05

ATC

cefadroxil; oral

2.4

33.5

227

953

WZC00, ,

SPAT

1.7

33.3

758

4842

L40.8

ICD-10 Finland

Other psoriasis

6.0

33.2

N02AX02

ATC

tramadol; systemic, rectal

1.4

33.1

2054

16249

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

33.0

320

1561

D01BA02

ATC

terbinafine; oral

1.5

33.0

1227

8784

L13.0

ICD-10 Finland

Dermatitis herpetiformis

9.8

33.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

32.6

1105

7750

J01XC01

ATC

fusidic acid; systemic

4.3

32.1

200

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

31.8

1179

8427

R4180

NOMESCO Finland

Podiatric therapy

4.0

31.7

228

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

31.4

1521

11463

L12.0

ICD-10 Finland

Bullous pemphigoid

7.4

31.4

XQ845

NOMESCO Finland

Dermatoscopy

3.4

31.2

112

333

ZY010

NOMESCO Finland

Hospital outpatient

2.2

31.1

260

1196

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

31.0

866

5809

D07AC03

ATC

desoximetasone; topical

3.7

30.7

274

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

30.5

2945

25036

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

30.5

219

944

N03AX12

ATC

[U] gabapentin; oral

1.6

30.4

754

4912

R50.9

ICD-10 Finland

Fever, unspecified

1.6

30.3

723

4665

L17

ICPC

Foot/toe symptom/complaint

1.5

30.0

1449

10897

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

29.9

647

4071

SPAT1255

SPAT

Intravenous administration of medicine

2.0

29.9

342

1773

-, ,

ICD-10 Finland

3.1

29.7

122

394

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

29.6

1056

7470

A02BC02

ATC

pantoprazole; systemic

1.4

29.5

3328

28974

E0001A1, ,

ATC

3.5

29.4

100

287

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

29.3

240

1094

T90

ICPC

Diabetes non-insulin dependent

1.5

29.1

1182

8582

H02AB07

ATC

prednisone; oral

1.7

29.1

598

3709

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

29.0

898

6158

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

29.0

911

6268

L13.9

ICD-10 Finland

Bullous disorder, unspecified

7.3

28.8

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

28.8

383

2089

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

28.6

181

736

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

28.5

1184

8632

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

28.5

1283

9504

L01

ICD-10 Finland

Impetigo

3.9

28.3

220

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

28.1

154

584

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

27.8

643

4110

R03BB04

ATC

tiotropium bromide; inhalant

1.8

27.8

472

2775

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.3

27.8

106

328

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

27.7

166

658

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.6

27.5

167

666

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

27.4

144

534

D05AX03

ATC

calcitriol; topical

3.9

27.3

212

J01MA02

ATC

ciprofloxacin; systemic

1.4

27.1

1826

14512

D11AX15

ATC

[U] pimecrolimus

+∞

27.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

26.7

2068

16807

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

26.6

1289

9662

C09AA02

ATC

enalapril; systemic

1.5

26.3

881

6131

205

Kela drug reimbursment

Chronic hypertension

1.5

26.3

1194

8837

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

26.1

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

26.1

L28.2

ICD-10 Finland

Other prurigo

23.3

26.0

C07AB07

ATC

bisoprolol; oral

1.4

26.0

2264

18729

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

8.9

25.9

SPAT1254

SPAT

Administration of medicine

1.6

25.9

677

4455

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

25.8

1690

13340

WQ021, ,

NOMESCO Finland

40.3

25.8

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

25.5

165

678

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.2

25.3

J01FA06

ATC

roxithromycin; oral

1.4

25.3

1791

14313

L04AA06

ATC

mycophenolic acid; systemic

3.1

25.2

106

348

AA1AD

NOMESCO Finland

CT of head and brain

1.4

25.2

1344

10235

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

25.1

444

2639

N06AX11

ATC

mirtazapine; oral

1.4

24.9

1568

12282

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

24.8

839

5845

J01MA14

ATC

moxifloxacin; systemic

1.8

24.7

421

2477

A10BA02

ATC

metformin; oral

1.4

24.5

1332

10164

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

24.5

805

5572

SPAT1211

SPAT

Application of soft bandage

1.8

24.5

406

2369

G47.3

ICD-10 Finland

Sleep apnoea

1.4

24.3

1102

8139

L01BA01

ATC

methotrexate; systemic

2.4

24.2

175

757

N03AX16

ATC

[U] pregabalin

1.5

24.1

1027

7491

J02AC01

ATC

fluconazole; systemic

1.4

24.0

1676

13334

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

24.0

353

1987

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

23.9

306

1647

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

5.0

23.7

100

WIX00

NOMESCO Finland

Allergy cleanup guidance

87.2

23.7

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

125.6

23.6

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

23.4

219

1054

J01AA02

ATC

doxycycline; systemic

1.4

23.3

3741

33748

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

23.3

1344

10350

R96

ICPC

Asthma

1.7

23.2

449

2734

OAB42, ,

SPAT

1.6

23.2

635

4217

ZXD05

NOMESCO Finland

Urgent procedure

1.4

23.2

1364

10536

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.8

23.1

115

415

N05AH04

ATC

quetiapine; oral

1.5

23.1

808

5664

S07

ICPC

Rash generalized

5.7

22.8

L27.2

ICD-10 Finland

Dermatitis due to ingested food

65.3

22.8

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

22.8

216

1045

QDB10, ,

SPAT

2.5

22.6

141

570

WQ007, ,

NOMESCO Finland

120.6

22.6

N05CF01

ATC

zopiclone; oral

1.4

22.6

1431

11184

ZZA00

NOMESCO Finland

Split skin graft

2.5

22.4

144

591

J01MA12

ATC

levofloxacin; systemic

1.5

22.4

828

5867

F10.24

ICD-10 Finland

Alcohol depence active use

3.2

22.4

288

C03DA01

ATC

spironolactone; oral

1.6

22.3

566

3691

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

22.3

261

1364

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.7

22.1

120

453

SPAT1151

SPAT

Treatment of major wounds

3.6

22.0

202

L04AB04

ATC

adalimumab; parenteral

2.7

22.0

119

449

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.6

21.9

131

519

XQ899

NOMESCO Finland

Other assessment of skin

8.1

21.7

UDC00

NOMESCO Finland

Ear microscopy

1.8

21.7

349

2018

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.6

21.6

127

499

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

21.6

505

3228

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

21.6

177

808

A02BC03

ATC

lansoprazole; oral

1.4

21.5

1250

9615

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

21.5

513

3297

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.2

21.4

270

SPAT1058

SPAT

PEF monitoring instruction

1.8

21.4

362

2124

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

21.3

112

416

C08CA01

ATC

amlodipine; oral

1.3

20.9

1760

14339

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

20.8

K08.3

ICD-10 Finland

Retained dental root

1.7

20.8

370

2200

M04AA01

ATC

allopurinol; systemic

1.6

20.8

593

3970

R03BA05

ATC

fluticasone; inhalant

1.5

20.8

771

5460

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

8.7

20.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.4

20.5

148

640

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

20.5

653

4479

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

20.4

238

1242

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

20.3

389

2361

J02AC02

ATC

itraconazole; systemic

1.5

20.3

750

5304

L84

ICD-10 Finland

Corns and callosities

2.2

20.3

171

790

P15

ICPC

Chronic alcohol abuse

2.3

20.3

155

688

P01AB01

ATC

metronidazole; oral, rectal

1.3

20.2

1757

14367

N07BB01

ATC

disulfiram; oral

2.1

20.1

202

1000

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

20.1

503

3269

A03

ICPC

Fever

1.5

20.0

766

5454

R03BA01

ATC

beclometasone; inhalant

1.5

19.9

596

4032

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

19.9

278

1539

-1, ,

NOMESCO Finland

1.4

19.9

1484

11854

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

19.9

159

719

K02.1

ICD-10 Finland

Caries of dentine

1.3

19.8

2775

24223

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

19.8

551

3667

A02BC01

ATC

omeprazole; systemic

1.4

19.8

1196

9242

A10AB05

ATC

insulin aspart; parenteral

1.7

19.6

358

2144

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.9

19.6

395

Kela drug reimbursment

Dupilumab

16.4

19.6

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

19.5

155

699

SPAT1240

SPAT

Therapeutic discussion

1.6

19.5

438

2772

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

19.4

403

2498

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

19.4

423

2656

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

19.4

233

1229

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

19.3

470

3032

J01FA01

ATC

erythromycin; systemic

1.5

19.2

563

3790

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

5.0

19.2

R03DC03

ATC

montelukast; oral

1.5

19.1

692

4870

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

19.1

607

4158

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

19.1

2129

17988

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

19.1

1423

11352

I50.0

ICD-10 Finland

Congestive heart failure

1.8

19.0

321

1881

D01AC03

ATC

econazole; topical

1.8

19.0

272

1518

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

19.0

376

2303

A10AE05

ATC

insulin detemir; parenteral

1.9

18.9

249

1353

C01CA24

ATC

epinephrine; parenteral

1.9

18.9

243

1311

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

18.9

114

455

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

18.8

287

1634

NHQ40

NOMESCO Finland

Amputation of toe

3.0

18.7

282

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

18.7

387

2398

A10AC01

ATC

insulin (human); parenteral

1.7

18.7

336

2005

P17

ICPC

Tobacco abuse

3.1

18.7

261

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

18.6

354

2145

WXQ24

NOMESCO Finland

UVB/UVA light therapy

100.4

18.6

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

18.5

278

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

18.5

344

2071

WX704

NOMESCO Finland

Intubation

1.7

18.4

386

2398

OAB50, ,

SPAT

1.7

18.4

392

2445

R05

ICPC

Cough

1.4

17.9

1111

8598

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

17.9

1706

14070

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

6.7

17.8

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.5

17.8

172

M54.5

ICD-10 Finland

Low back pain

1.3

17.8

1643

13489

B35.4

ICD-10 Finland

Tinea corporis

3.0

17.7

253

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

17.7

106

421

L04AA13

ATC

[U] leflunomide

2.5

17.7

115

475

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

17.7

370

2298

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

17.7

121

512

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.0

17.7

259

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

17.6

187

944

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.3

17.6

135

600

N06AX21

ATC

duloxetine; oral

1.5

17.6

510

3423

B01AB05

ATC

enoxaparin; parenteral

1.3

17.6

1388

11141

WX720

NOMESCO Finland

Own respiration

1.9

17.6

240

1320

N06AA12

ATC

doxepin; systemic

1.9

17.5

216

1149

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

17.4

314

1875

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

17.4

347

2130

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

17.3

397

2522

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

17.3

103

408

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

17.3

540

3682

R53

ICD-10 Finland

Malaise and fatigue

1.4

17.3

1111

8641

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

17.3

300

1772

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

17.2

794

5845

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

17.2

190

974

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

17.1

340

2085

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

17.0

695

5000

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

17.0

508

3431

WQ020, ,

NOMESCO Finland

31.6

17.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

16.9

435

2841

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

16.9

158

762

N02AA05

ATC

oxycodone; systemic

1.4

16.8

797

5891

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

4.8

16.8

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

16.8

156

750

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

16.8

3134

28117

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

16.7

1058

8208

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

16.7

299

1783

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

16.6

188

971

R95

ICPC

Chron obstructive pulmonary disease

2.2

16.6

145

680

R06AX26

ATC

fexofenadine; oral

1.8

16.6

274

1595

L50.0

ICD-10 Finland

Allergic urticaria

2.4

16.6

113

477

KMAK, ,

NOMESCO Finland

1.3

16.6

2304

19906

EBA00

NOMESCO Finland

Extraction of tooth

1.3

16.5

1669

13840

S08

ICPC

Skin colour change

1.8

16.5

245

1383

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

16.4

3413

30989

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.5

16.4

101

407

WX213

NOMESCO Finland

Lower leg blockade

3.6

16.4

148

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

16.4

1018

7871

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.3

16.3

126

562

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.7

16.3

139

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

16.2

376

2396

P01BA02

ATC

hydroxychloroquine; oral

1.7

16.1

336

2084

SFA10

NOMESCO Finland

One-surface restoration

1.3

16.1

2545

22309

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

16.1

3400

30892

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

16.1

343

2141

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

16.0

352

2213

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

16.0

544

3775

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.4

16.0

165

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

16.0

1960

16649

J04AB02

ATC

rifampicin; systemic

3.0

16.0

226

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

15.9

317

1943

J45

ICD-10 Finland

Asthma

1.6

15.9

424

2791

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

15.7

446

2979

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

15.7

415

2728

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.6

15.6

340

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

15.6

100

411

L71.9

ICD-10 Finland

Rosacea, unspecified

2.3

15.6

113

491

B01AC04

ATC

clopidogrel; oral

1.4

15.6

710

5209

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

15.5

1734

14544

M25.5

ICD-10 Finland

Pain in joint

1.3

15.5

1443

11816

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

15.4

110

475

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

15.4

194

1040

N05AA02

ATC

levomepromazine; systemic

2.0

15.4

173

893

J46

ICD-10 Finland

Status asthmaticus

2.2

15.4

121

545

N05CD07

ATC

temazepam; oral

1.5

15.3

464

3142

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

15.3

160

805

N06AA09

ATC

amitriptyline; systemic

1.6

15.3

384

2495

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

15.2

203

1108

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

15.2

2380

20782

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

15.2

362

S91

ICPC

Psoriasis

3.5

15.2

146

A10AE04

ATC

insulin glargine; parenteral

1.5

15.2

430

2868

QXA70

NOMESCO Finland

Guidance related to rash and skin care

28.7

15.2

L14

ICPC

Leg/thigh symptom/complaint

1.6

15.1

354

2263

L40

ICD-10 Finland

Psoriasis

2.5

15.1

382

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

15.0

468

3187

N05BA01

ATC

diazepam; systemic, rectal

1.5

15.0

530

3703

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

15.0

952

7373

C02AC05

ATC

moxonidine; oral

1.9

15.0

202

1107

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

14.9

242

1402

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

6.5

14.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

14.9

191

1030

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.5

14.9

396

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.5

14.9

372

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

6.8

14.8

T78.3

ICD-10 Finland

Angioneurotic oedema

3.0

14.8

225

M10.9

ICD-10 Finland

Gout, unspecified

1.6

14.7

309

1921

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

14.7

302

1867

B07.9

ICD-10 Finland

Verruca simplex

2.0

14.7

156

789

A01

ICPC

Pain general/multiple sites

1.5

14.6

436

2942

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

14.6

1300

10566

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.6

2149

18602

H01

ICPC

Ear pain/earache

1.5

14.6

485

3349

XQ801

NOMESCO Finland

Intracutantest

5.1

14.6

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

14.5

248

1461

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

14.4

1238

10008

SPAT1229

SPAT

Assessment of need for aid

1.6

14.3

306

1911

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

14.3

1181

9497

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

14.3

293

1811

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

14.2

1567

13084

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

14.2

161

833

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

14.1

181

977

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

6.4

14.1

R42

ICD-10 Finland

Dizziness and giddiness

1.3

14.1

970

7599

L50.8

ICD-10 Finland

Other urticaria

2.7

14.0

283

N03AG01

ATC

valproic acid; systemic, rectal

1.7

14.0

242

1429

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

5.4

14.0

SPAT1097

SPAT

Recording of ECG

1.4

14.0

602

4367

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

13.9

588

4252

S06.0

ICD-10 Finland

Concussion

1.5

13.9

453

3115

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

13.9

189

1040

N05AH03

ATC

olanzapine; systemic

1.7

13.8

265

1609

H70

ICPC

Otitis externa

2.3

13.8

100

435

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

13.8

270

1649

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.7

232

1361

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

13.7

3144

28549

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

13.7

962

7556

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

13.7

158

824

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

13.6

301

1898

L85.89

ICD-10 Finland

Other specified epidermal thickening

14.7

13.5

Z72.0

ICD-10 Finland

Tobacco use

2.1

13.5

124

595

L30.2

ICD-10 Finland

Cutaneous autosensitization

34.1

13.5

A06AD11

ATC

lactulose; oral

1.4

13.5

603

4404

K07

ICPC

Swollen ankles/oedema

1.8

13.4

199

1125

S01GX08

ATC

ketotifen; ophthalmic

1.9

13.3

177

966

R03BA02

ATC

budesonide; inhalant

1.4

13.3

707

5314

N02BF01

ATC

gabapentin; oral

1.5

13.3

448

3100

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

13.3

125

605

L43.8

ICD-10 Finland

Other lichen planus

2.5

13.3

314

L29

ICD-10 Finland

Pruritus

2.9

13.3

212

D06BX01

ATC

metronidazole; topical

1.5

13.3

418

2853

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

13.3

424

C09CA01

ATC

losartan; oral

1.3

13.3

1115

8975

A08

ICPC

Swelling

1.7

13.2

241

1444

SFA30

NOMESCO Finland

Three-surface restoration

1.3

13.2

1904

16383

SPAT1059

SPAT

Spirometry at the office

1.8

13.2

214

1241

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.7

13.2

SPAT1283

SPAT

Restricted health certificate

1.4

13.2

663

4940

N05AH02

ATC

clozapine; systemic

2.5

13.1

328

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.5

13.1

334

QBA10

NOMESCO Finland

Incision of skin of trunk

3.0

13.1

187

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

13.1

201

1148

A10BH01

ATC

sitagliptin; oral

1.5

13.0

408

2781

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

12.9

217

1272

N06AB04

ATC

citalopram; systemic

1.3

12.9

844

6553

J30.3

ICD-10 Finland

Other allergic rhinitis

2.0

12.9

135

681

N05AF03

ATC

chlorprothixene; systemic

2.2

12.8

110

515

M48.0

ICD-10 Finland

Spinal stenosis

1.4

12.7

498

3548

B35.2

ICD-10 Finland

Tinea manuum

5.8

12.7

SPAT1285

SPAT

Provision of consultation response

1.7

12.7

220

1300

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.4

12.7

134

N05AX08

ATC

risperidone; systemic

1.6

12.7

341

2249

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

5.1

12.7

N06AB03

ATC

fluoxetine; oral

1.4

12.6

492

3502

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

12.6

182

1020

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

70.0

12.6

JN4AD

NOMESCO Finland

Body CT examination

1.4

12.5

498

3561

N06AX16

ATC

venlafaxine; oral

1.4

12.5

578

4245

X58

ICD-10 Finland

Exposure to other specified factors

1.4

12.5

625

4652

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.6

12.3

284

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

12.3

159

861

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.8

12.3

184

1043

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.8

12.3

205

L04AB01

ATC

etanercept; parenteral

2.6

12.3

279

A07AA02

ATC

nystatin; oral

1.7

12.2

225

1352

L71.8

ICD-10 Finland

Other rosacea

2.6

12.2

268

127

Kela drug reimbursment

Transplant complication

2.6

12.2

268

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

3.7

12.2

104

D07XB01

ATC

flumetasone; topical

3.6

12.1

109

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

12.1

2500

22307

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

12.1

138

718

A10BK03

ATC

empagliflozin; oral

1.5

12.0

451

3186

H02AB09

ATC

hydrocortisone; systemic

2.2

12.0

102

475

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

1.9

12.0

159

868

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

12.0

573

4228

L16

ICPC

Ankle symptom/complaint

1.4

12.0

501

3611

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

12.0

456

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.1

12.0

111

535

S22.3

ICD-10 Finland

Fracture of rib

1.6

12.0

318

2092

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

3.8

12.0

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.2

12.0

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

11.9

438

QXB99, ,

SPAT

2.0

11.9

126

638

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.0

11.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

11.9

1003

8063

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

11.9

419

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.7

11.9

237

R51.80

ICD-10 Finland

Headache

1.4

11.8

628

4717

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

11.8

554

4076

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

11.8

145

773

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

11.8

544

3991

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.6

11.8

267

C09AA05

ATC

ramipril; oral

1.3

11.8

1046

8465

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

11.8

240

1482

P16

ICPC

Acute alcohol abuse

2.4

11.8

309

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.7

873

6897

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

11.7

100

467

B01AA03

ATC

warfarin; systemic

1.3

11.7

764

5923

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.8

11.7

205

A02BC05

ATC

esomeprazole; systemic

1.2

11.7

1741

14980

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.1

11.6

103

488

N18.0

ICD-10 Finland

End-stage renal disease

3.0

11.6

168

SPAT1216

SPAT

Assessment of functional ability

1.4

11.6

607

4547

ZYC01, ,

SPAT

1.4

11.6

457

3260

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

11.6

751

5817

ZXA10

NOMESCO Finland

Bilateral

1.3

11.6

734

5666

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

11.5

138

729

N06AX12

ATC

bupropion; oral

1.6

11.5

280

1805

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

11.5

1080

8798

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.7

11.5

224

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

11.5

130

674

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

11.4

1100

8990

T82

ICPC

Obesity

1.8

11.4

171

970

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

11.4

318

2116

P29

ICPC

Psychological sympt/compl other

1.6

11.4

297

1947

R06.2

ICD-10 Finland

Wheezing

1.7

11.3

183

1062

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

11.3

396

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

11.3

670

5121

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.3

11.3

365

R55

ICD-10 Finland

Syncope and collapse

1.4

11.3

447

3192

S19

ICPC

Skin injury other

1.8

11.2

158

880

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

11.2

171

976

D69.0

ICD-10 Finland

Allergic purpura

3.6

11.2

101

OAB74, ,

SPAT

2.8

11.2

205

B35.1

ICD-10 Finland

Tinea unguium

1.6

11.1

282

1839

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.2

11.0

426

L03

ICPC

Low back symptom/complaint

1.3

11.0

1248

10399

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

11.0

367

2535

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.8

11.0

190

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

11.0

542

4021

N05BA04

ATC

oxazepam; oral

1.3

10.9

1097

9005

WX892

NOMESCO Finland

Monitored bed care

1.5

10.9

306

2037

WZC30, ,

SPAT

1.5

10.9

369

2554

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.6

10.9

236

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

10.9

949

7652

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

10.9

261

1678

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

10.8

866

6904

C08CA13

ATC

lercanidipine; oral

1.4

10.8

586

4413

A05

ICPC

Feeling ill

1.6

10.8

231

1445

J01FA09

ATC

clarithromycin; systemic

1.3

10.8

1292

10831

L70.0

ICD-10 Finland

Acne vulgaris

2.1

10.8

470

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

10.7

252

1612

L40.4

ICD-10 Finland

Guttate psoriasis

4.4

10.7

R03BA08

ATC

ciclesonide; inhalant

1.5

10.7

330

2243

J01FA10

ATC

azithromycin; systemic

1.2

10.7

2506

22533

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.6

10.7

233

A12AA04

ATC

calcium carbonate; oral

2.5

10.6

263

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

10.6

103

506

L25.8

ICD-10 Finland

Unspecified contact dermatitis due to other agents

60.1

10.6

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.6

10.6

222

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

2.8

10.6

177

L12

ICPC

Hand/finger symptom/complaint

1.3

10.6

718

5592

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.4

10.6

312

I50.1

ICD-10 Finland

Left ventricular failure

1.7

10.6

206

1258

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

10.5

392

2766

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.8

10.5

189

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

10.5

259

1676

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

3.6

10.5

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

10.5

167

966

C10AC01

ATC

colestyramine; oral

2.0

10.4

106

530

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

10.4

476

WXQ20

NOMESCO Finland

UVA broad spectrum light therapy

110.2

10.4

1653, ,

NOMESCO Finland

110.2

10.4

L04AC10

ATC

secukinumab; parenteral

4.1

10.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

10.4

400

2840

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.6

10.4

225

1412

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

10.4

264

1721

SPAT1247

SPAT

Outpatient detoxication and monitoring

4.2

10.3

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

10.3

418

E000005, ,

ATC

32.6

10.3

K28

ICPC

Limited function/disability (K)

2.1

10.3

478

TGC00

NOMESCO Finland

Bronchial lavation

2.0

10.3

102

505

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.3

10.3

316

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

10.3

2159

19177

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

10.3

186

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

10.2

454

3306

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

4.9

10.2

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.9

10.2

EB1VA, ,

NOMESCO Finland

1.3

10.2

761

6005

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.5

10.2

380

2681

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.9

10.2

159

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

10.2

241

1545

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

10.2

734

5766

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

10.2

380

2683

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.2

10.1

382

S84

ICPC

Impetigo

4.1

10.1

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.1

10.1

T74.1

ICD-10 Finland

Physical abuse

2.3

10.1

325

RJ411, ,

NOMESCO Finland

3.9

10.1

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

10.1

122

648

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

10.1

1059

8732

N02BF02

ATC

pregabalin; oral

1.5

10.1

275

1821

J01CF02

ATC

cloxacillin; systemic

2.1

10.1

429

R01AD11

ATC

triamcinolone; nasal

1.5

10.1

325

2231

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

10.0

263

1726

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

10.0

139

771

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

10.0

134

735

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

10.0

133

728

M10.0

ICD-10 Finland

Idiopathic gout

1.8

10.0

146

823

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

10.0

254

1656

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.9

10.0

118

622

C84.0

ICD-10 Finland

Mycosis fungoides

14.6

10.0

L98.1

ICD-10 Finland

Factitial dermatitis

14.6

10.0

WQ066, ,

NOMESCO Finland

40.1

10.0

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

2.9

9.9

156

R03AC12

ATC

salmeterol; inhalant

1.7

9.9

160

929

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.9

727

5725

K85

ICD-10 Finland

Acute pancreatitis

2.3

9.9

303

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

9.9

421

3044

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.8

9.9

173

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

9.9

203

1258

C08CA02

ATC

felodipine; oral

1.4

9.9

366

2581

1200, ,

NOMESCO Finland

16.7

9.9

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

9.8

373

2641

PD4AD

NOMESCO Finland

CT of lower extremity arteries

2.9

9.8

157

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.3

9.8

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

9.8

195

1198

K90.0

ICD-10 Finland

Coeliac disease

1.9

9.8

115

605

R03AC03

ATC

terbutaline; inhalant

1.4

9.8

522

3921

A07EC02

ATC

mesalazine; oral, rectal

1.6

9.8

205

1277

N06

ICPC

Sensation disturbance other

2.7

9.8

191

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

4.5

9.8

L43.0

ICD-10 Finland

Hypertrophic lichen planus

4.0

9.8

E87.6

ICD-10 Finland

Hypokalaemia

1.8

9.7

141

793

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

9.7

732

5784

SFA20

NOMESCO Finland

Two-surface restoration

1.2

9.7

2642

24006

J01CA04

ATC

amoxicillin; systemic

1.2

9.7

3873

36514

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

9.7

750

5947

IHZ05, ,

SPAT

1.7

9.7

165

973

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.9

9.7

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

9.6

580

4437

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

9.6

259

1711

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.0

9.6

100

505

L04AB06

ATC

golimumab; parenteral

3.1

9.6

122

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.5

9.6

246

R03AC13

ATC

formoterol; inhalant

1.7

9.6

182

1106

TK800

NOMESCO Finland

Hemodialysis

2.1

9.6

438

RS340, ,

NOMESCO Finland

5.0

9.6

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

9.5

1186

9964

L56.4

ICD-10 Finland

Polymorphous light eruption

4.4

9.5

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

9.5

256

1692

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.6

9.5

200

1248

S17

ICPC

Abrasion/scratch/blister

2.0

9.5

453

SPAT1324

SPAT

Screening procedure

1.3

9.5

644

5017

UKC02

NOMESCO Finland

Cystoscopy

1.3

9.4

664

5196

PE1AT

NOMESCO Finland

Femoral artery PTA

2.6

9.4

212

A10BJ06

ATC

semaglutide; parenteral

1.6

9.4

223

1431

WVA20

NOMESCO Finland

Medicine administration

1.9

9.4

118

635

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.4

990

8160

WVA20, ,

SPAT

1.7

9.4

156

914

WQ022, ,

NOMESCO Finland

+∞

9.4

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

9.4

240

1568

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.3

9.4

298

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

9.4

349

ZX120, ,

SPAT

2.3

9.3

292

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

9.3

343

SCA02

NOMESCO Finland

Preventive oral health care

1.4

9.3

397

2871

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.5

9.3

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.7

9.3

173

S91.0

ICD-10 Finland

Open wound of ankle

2.7

9.3

173

L04AC05

ATC

ustekinumab; parenteral

3.7

9.3

S01GX02

ATC

levocabastine; ophthalmic

1.6

9.3

203

1278

SGA01

NOMESCO Finland

Emergency treatment

1.3

9.2

674

5300

A10AB04

ATC

insulin lispro; parenteral

1.8

9.2

124

682

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

4.0

9.2

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.2

1157

9727

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

9.2

302

2081

-50

ICPC

Medication/prescr/renewal

1.7

9.2

156

920

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.5

9.2

L08

ICPC

Shoulder symptom/complaint

1.3

9.2

969

7987

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

9.2

378

2719

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.9

9.2

110

584

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

9.1

234

1529

A07EA06

ATC

budesonide; oral, local oral

1.8

9.1

141

809

R52.9

ICD-10 Finland

Pain, unspecified

1.4

9.1

405

2950

R01AD09

ATC

mometasone; nasal

1.2

9.1

1910

16903

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

9.1

381

2746

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

9.1

160

952

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

9.1

106

557

P03

ICPC

Feeling depressed

1.4

9.1

384

2774

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.6

9.0

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

9.0

111

C10AA01

ATC

simvastatin; oral

1.2

9.0

1721

15095

C03AA03

ATC

hydrochlorothiazide; oral

1.4

9.0

337

2381

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

9.0

275

1867

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.7

9.0

165

SPAT1053

SPAT

Memory test

1.3

9.0

528

4025

SFA00

NOMESCO Finland

Small restoration

1.3

9.0

577

4457

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

9.0

349

SBA00

NOMESCO Finland

Microbiological examinations

1.9

9.0

101

525

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.0

8.9

463

K60.3

ICD-10 Finland

Anal fistula

2.2

8.9

337

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

24.0

8.9

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

8.9

244

1621

Z01.2

ICD-10 Finland

Dental examination

1.2

8.9

2035

18152

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.8

8.8

128

721

E66.0

ICD-10 Finland

Obesity due to excess calories

2.7

8.8

178

C09BA02

ATC

enalapril and diuretics; systemic

1.5

8.8

310

2164

R01AD12

ATC

fluticasone furoate; nasal

1.2

8.8

1272

10846

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.6

8.8

196

J05AB01

ATC

aciclovir; systemic

1.3

8.8

859

7013

A11CC03

ATC

alfacalcidol; systemic

2.0

8.8

487

W19

ICD-10 Finland

Unspecified fall

1.4

8.8

390

2842

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

8.8

147

864

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.8

416

3065

Z37.0

ICD-10 Finland

Single live birth

0.5

8.8

1724

R18

ICD-10 Finland

Ascites

2.0

8.8

419

S10

ICPC

Boil/carbuncle

1.5

8.8

241

1601

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.0

8.7

129

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

8.7

122

680

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

8.7

240

1594

SPAT1193

SPAT

Pap smear

1.4

8.7

318

2236

R06AX18

ATC

acrivastine; oral

1.9

8.7

502

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.6

8.7

191

J01CR50

ATC

combinations of penicillins; systemic

7.2

8.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

8.7

1750

15411

WX730

NOMESCO Finland

Conventional respirator

2.3

8.7

295

ZXH06, ,

SPAT

1.6

8.7

206

1323

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.7

338

2406

K92.0

ICD-10 Finland

Haematemesis

1.9

8.7

517

L40.2

ICD-10 Finland

Acrodermatitis continua

50.1

8.7

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

8.7

215

1396

A28

ICPC

Limited function/disability NOS

1.3

8.7

696

5544

QXA70, ,

SPAT

2.2

8.6

296

Z08

ICPC

Social welfare problem

2.4

8.6

246

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.9

8.6

141

N03AX09

ATC

lamotrigine; oral

1.6

8.6

174

1075

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.4

8.6

228

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

4.6

8.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

8.5

256

1733

E66.8

ICD-10 Finland

Other obesity

1.6

8.5

210

1362

Z94.0

ICD-10 Finland

Kidney transplant status

2.6

8.5

176

R04.0

ICD-10 Finland

Epistaxis

1.5

8.5

300

2097

M03BX02

ATC

tizanidine; oral

1.2

8.5

2754

25291

D11

ICPC

Diarrhoea

1.4

8.5

466

3517

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.1

8.4

371

R52.2

ICD-10 Finland

Other chronic pain

1.7

8.4

148

882

XQ806

NOMESCO Finland

Minimal Erythema Dose (MED) test

90.2

8.4

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

8.4

170

1052

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.8

8.4

114

631

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.8

8.4

117

653

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

8.4

947

7862

B08.1

ICD-10 Finland

Molluscum contagiosum

4.6

8.3

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

8.3

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

8.3

118

661

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.0

8.3

122

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

8.3

106

575

N05AD01

ATC

haloperidol; systemic

1.8

8.3

120

677

Z00.0

ICD-10 Finland

General medical examination

1.3

8.3

782

6356

H29

ICPC

Ear symptom/complaint other

1.3

8.3

482

3670

L28

ICPC

Limited function/disability (L)

1.3

8.2

752

6086

J43.9

ICD-10 Finland

Emphysema, unspecified

2.2

8.2

296

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

8.2

404

2995

SPAT1252

SPAT

Overall medication plan or its review

1.5

8.2

252

1714

H3603, E103,

ICD-10 Finland

2.7

8.2

162

NHG20

NOMESCO Finland

Fusion of talocrural joint

3.2

8.2

Z2221

NOMESCO Finland

Medical doctor

0.8

8.2

756

9233

L15

ICPC

Knee symptom/complaint

1.2

8.2

1033

8676

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.6

8.2

168

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.6

8.2

198

1279

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

8.1

228

AN1

Coronary angiography

1.4

8.1

422

3155

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

8.1

495

3793

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.1

615

4859

A10AD05

ATC

insulin aspart; parenteral

2.1

8.1

324

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.6

8.1

169

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.3

8.1

260

E86

ICD-10 Finland

Volume depletion

1.9

8.1

523

L44.0

ICD-10 Finland

Pityriasis rubra pilaris

33.4

8.1

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

8.1

395

2926

A10AE06

ATC

insulin degludec; parenteral

1.7

8.1

142

847

L24.5

ICD-10 Finland

Irritant contact dermatitis due to other chemical products

17.2

8.1

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

8.1

995

8336

R21

ICPC

Throat symptom/complaint

1.3

8.0

817

6697

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

8.0

489

N05CF02

ATC

zolpidem; oral

1.3

8.0

677

5425

R29

ICPC

Respiratory symptom/complaint other

1.5

8.0

275

1914

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

8.0

1055

8903

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

8.0

111

619

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

8.0

102

554

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

8.0

889

7364

HMAK, ,

NOMESCO Finland

1.4

8.0

441

3331

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

8.0

150

911

K50.8

ICD-10 Finland

Other Crohn disease

2.3

8.0

268

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.5

8.0

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.2

7.9

275

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.6

7.9

162

1006

SAA04

NOMESCO Finland

Special examination of mouth

1.6

7.9

199

1298

WVA40, ,

SPAT

2.9

7.9

126

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

7.9

102

556

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.7

7.9

154

SPAT1101

SPAT

Orthostatic test

1.7

7.9

150

914

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

7.9

201

1315

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.0

7.9

375

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

7.8

178

1133

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.8

701

5657

WX402

NOMESCO Finland

General anaesthesia

1.2

7.8

932

7776

R07.3

ICD-10 Finland

Other chest pain

1.4

7.8

399

2976

SPAT1139

SPAT

Nutrition survey

1.8

7.8

122

704

NH3CG

NOMESCO Finland

Extensive MRI of foot

3.1

7.8

100

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.6

7.8

193

1253

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

7.8

344

2504

SPAT1104

SPAT

Monitoring of emergency patient

1.5

7.8

247

1691

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

4.1

7.8

K04.0

ICD-10 Finland

Pulpitis

1.4

7.8

349

2548

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

7.8

506

3914

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.2

7.8

SPAT1284

SPAT

Extensive health certificate

1.8

7.8

104

573

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

7.8

151

925

L04AC18

ATC

risankizumab; parenteral

6.9

7.8

V03AE01

ATC

polystyrene sulfonate; oral

2.4

7.7

221

XQ855, ,

SPAT

2.3

7.7

246

L09

ICPC

Arm symptom/complaint

1.6

7.7

188

1216

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.2

7.7

304

S91.3

ICD-10 Finland

Open wound of other parts of foot

1.8

7.7

103

567

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

7.7

230

1556

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.4

7.7

222

B01AB10

ATC

tinzaparin; parenteral

1.3

7.7

443

3368

L24

ICD-10 Finland

Irritant contact dermatitis

7.4

7.7

IHZ04, ,

SPAT

2.1

7.7

325

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

7.7

192

1251

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.6

640

5122

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

4.5

7.6

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.4

7.6

198

R31

ICD-10 Finland

Unspecified haematuria

1.4

7.6

414

3120

M70.2

ICD-10 Finland

Olecranon bursitis

1.7

7.6

136

816

SPAT1325

SPAT

Vaccination

1.2

7.6

1331

11545

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

7.6

286

2026

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

7.6

178

1143

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

7.6

107

600

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.5

7.6

175

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.5

7.6

175

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

7.5

235

1604

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

7.5

208

1384

OAB44, ,

SPAT

1.4

7.5

400

3002

D82

ICPC

Teeth/gum disease

1.2

7.5

1581

13937

H60.3

ICD-10 Finland

Other infective otitis externa

1.9

7.5

486

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

4.2

7.5

SPA47

NOMESCO Finland

Precision impression for denture

1.8

7.5

108

610

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

7.4

289

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

7.4

146

897

-44

ICPC

Preventive immunization/medic

1.4

7.4

300

2151

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

7.4

498

3869

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

7.4

442

3376

Z72.1

ICD-10 Finland

Alcohol use

2.3

7.4

232

GX1E5, ,

SPAT

2.2

7.4

251

L29.2

ICD-10 Finland

Pruritus vulvae

2.5

7.4

171

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.1

7.4

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

7.4

277

1960

-69

ICPC

Other reason for encounter NEC

1.7

7.4

139

845

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

2.9

7.4

109

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4.0

7.3

B35.8

ICD-10 Finland

Other dermatophytoses

4.0

7.3

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

7.3

426

3242

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.3

7.3

227

B82

ICPC

Anaemia other/unspecified

1.7

7.3

117

681

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

7.3

143

69009

ICD-8 Finland

Seborrhoeic dermatitis, Unspecified

+∞

7.3

A10AD04

ATC

insulin lispro; parenteral

3.6

7.3

L04AC21

ATC

bimekizumab; systemic

10.9

7.3

AA3AD

NOMESCO Finland

CT of face

2.6

7.3

149

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

7.3

192

1266

L85.1

ICD-10 Finland

Acquired keratosis [keratoderma] palmaris et plantaris

9.4

7.3

Z49.2

ICD-10 Finland

Other dialysis

2.8

7.2

121

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

7.2

373

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

3.8

7.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

7.2

239

1651

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

7.2

225

1536

R09

ICPC

Sinus symptom/complaint

1.4

7.2

308

2230

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.7

7.2

133

804

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

7.2

232

1595

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

2.9

7.2

116

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.9

7.2

116

N05AF05

ATC

zuclopenthixol; systemic

2.6

7.2

150

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.0

7.2

388

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.6

7.2

141

867

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

7.2

234

1613

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.2

718

5871

A29

ICPC

General symptom/complaint other

1.3

7.1

536

4228

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

30.0

7.1

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

7.1

453

3492

A41.8

ICD-10 Finland

Other specified sepsis

2.0

7.1

382

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.7

7.1

130

784

Z3231

NOMESCO Finland

Registered nurse

1.2

7.1

1085

9276

WZB00, ,

SPAT

1.4

7.1

353

2621

L03.8

ICD-10 Finland

Cellulitis of other sites

3.1

7.1

SPAT1210

SPAT

Application of cast or individual aid

1.6

7.1

145

900

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

7.1

143

885

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

3.2

7.1

WX950, ,

SPAT

2.4

7.1

199

A10BB12

ATC

glimepiride; oral

1.5

7.1

246

1716

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.1

113

657

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.5

7.1

169

P01

ICPC

Feeling anxious/nervous/tense

1.3

7.0

459

3552

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

7.0

448

3455

J45.8

ICD-10 Finland

Mixed asthma

1.7

7.0

110

636

120

Kela drug reimbursment

Hypogammaglobulinaemia

8.8

7.0

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

1.9

7.0

433

49300

ICD-8 Finland

Asthma, bronchiale

1.9

7.0

433

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

7.0

236

1636

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

7.0

182

1196

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

7.0

177

1156

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

7.0

114

667

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.5

7.0

170

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

7.0

1487

13109

OAB95, ,

SPAT

0.6

7.0

150

2322

ZXC50

NOMESCO Finland

Cryotherapy

1.8

7.0

107

616

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

6.9

217

1483

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

3.0

6.9

102

C07AG02

ATC

carvedilol; oral

1.5

6.9

214

1459

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.6

6.9

152

961

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

6.9

513

4040

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.8

6.9

507

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.5

6.9

159

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

6.9

220

1510

QDG00

NOMESCO Finland

Debridement of bedsore of lower limb

7.5

6.9

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

6.9

124

746

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

4.0

6.9

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

4.0

6.9

R05

ICD-10 Finland

Cough

1.2

6.9

860

7206

N06AB10

ATC

escitalopram; oral

1.2

6.9

789

6551

N17.8

ICD-10 Finland

Other acute renal failure

2.2

6.9

253

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

6.8

265

1887

C07AB02

ATC

metoprolol; systemic

1.2

6.8

759

6277

R03DA04

ATC

theophylline; systemic, rectal

1.6

6.8

170

1107

NG4AD

NOMESCO Finland

Lower leg CT

3.4

6.8

SPD01

NOMESCO Finland

Mucosa-supported complete denture

2.5

6.8

172

SDA03

NOMESCO Finland

Periodontal treatment

1.2

6.8

1741

15578

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

6.8

238

1663

A12BA01

ATC

potassium chloride; oral

1.6

6.8

143

895

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

6.8

203

1375

C10AA05

ATC

atorvastatin; oral

1.2

6.8

1812

16268

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

6.8

241

S01AD03

ATC

aciclovir; ophthalmic

1.7

6.8

118

703

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.8

447

3464

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.5

6.8

175

1149

N05BA02

ATC

chlordiazepoxide; systemic

1.8

6.8

496

XF600, ,

SPAT

1.6

6.8

157

1006

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

9.3

6.8

H3601, E103,

ICD-10 Finland

2.6

6.8

143

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.6

6.8

149

L10.2

ICD-10 Finland

Pemphigus foliaceus

40.1

6.8

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.9

6.8

418

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.4

6.7

179

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

1.8

6.7

519

Z2446

NOMESCO Finland

Social worker

1.5

6.7

227

1576

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.1

6.7

269

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

6.7

490

3855

M01AE02

ATC

naproxen; oral, rectal

1.2

6.7

2451

22555

SPAT1172

SPAT

Guidance concerning hydration

1.9

6.7

413

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.3

6.7

205

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.3

6.7

205

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

6.7

481

3776

P06

ICPC

Sleep disturbance

1.3

6.6

504

3982

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.6

6.6

1547

C01DA14

ATC

isosorbide mononitrate; oral

1.3

6.6

575

4622

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.0

6.6

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

6.6

261

1867

S80.0

ICD-10 Finland

Contusion of knee

1.4

6.6

288

2096

S86

ICPC

Dermatitis seborrhoeic

3.6

6.6

S01.0

ICD-10 Finland

Open wound of scalp

1.4

6.6

310

2285

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1.9

6.6

415

S74

ICPC

Dermatophytosis

1.9

6.6

401

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

219

120

19.00

276.28

1.5

28.43

21.71

u/ml

0.58

(40768443) Skin Pathology biopsy report

619

1453

4.70

245.00

1.4

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

181

109

17.16

217.94

1.3

1.4

256.92

210.00

titre

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

177

102

17.92

217.76

1.3

1.4

48.00

71.67

titre

—

(3005322) IgE [Units/volume] in Serum or Plasma

754

2512

3.34

179.35

1.5

1.3

689.91

149.72

u/ml

7.76

716

2328

(3007853) Bacteria identified in Skin by Aerobe culture

1170

5079

2.68

172.13

2.2

1.7

—

(3000494) Fungus identified in Specimen by Culture

1043

5183

2.26

108.88

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1689

10082

2.00

108.73

6.8

4.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2174

14449

1.86

98.88

3.3

2.7

58.95

66.25

u/l

0.66

2039

13405

(3001604) Monocytes [#/volume] in Blood

3105

23041

1.85

98.84

8.6

6.1

0.62

0.59

e9/l

12.18

2864

19660

(3006315) Basophils [#/volume] in Blood

3108

23112

1.85

97.79

8.7

6.2

0.05

0.04

e9/l

11.12

2866

19733

(3013115) Eosinophils [#/volume] in Blood

3179

23840

1.85

96.95

8.9

6.3

0.23

0.19

e9/l

23.90

2945

20717

(3019198) Lymphocytes [#/volume] in Blood

3132

23599

1.81

91.63

8.8

6.2

1.89

1.91

e9/l

0.27

2920

20667

(3013650) Neutrophils [#/volume] in Blood by Automated count

3294

25847

1.74

77.12

11.6

9.6

4.33

4.14

e9/l

5.53

3062

22313

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3090

23967

1.71

73.99

6.9

6.7

11.49

11.76

umol/l

0.37

2951

22880

(3024561) Albumin [Mass/volume] in Serum or Plasma

2696

20317

1.67

70.58

6.2

5.2

34.88

35.66

g/l

9.70

2539

19087

(3032080) INR in Blood by Coagulation assay

2786

21182

1.67

70.43

18.4

15.3

1.24

1.26

inr

1.51

2433

17771

(3029937) Albumin [Presence] in Urine by Test strip

1924

13274

1.71

70.30

5.3

3.9

0.00

estimate

2.14

778

4646

(3023368) Bacteria identified in Blood by Culture

1854

12682

1.72

69.78

5.5

4.3

—

(3042936) Bacteria identified in Isolate by Culture

1097

6477

1.88

67.82

2.5

2.0

—

(3019069) Monocytes/Leukocytes in Blood

2783

21320

1.65

66.88

9.0

6.5

9.05

8.88

2.23

2679

19967

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2449

18209

1.65

65.88

5.2

3.7

0.01

0.18

estimate

0.74

714

4135

(3006504) Eosinophils/Leukocytes in Blood

2772

21275

1.64

65.61

8.8

6.4

3.22

2.80

13.83

2663

19908

(3022096) Basophils/Leukocytes in Blood

2760

21276

1.63

63.22

9.0

6.5

0.70

0.67

1.95

2653

19894

(3002030) Lymphocytes/Leukocytes in Blood

2817

21862

1.62

62.47

8.9

6.4

26.56

27.65

6.39

2723

20676

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4053

34583

1.76

61.57

10.2

8.2

81.58

78.80

u/l

2.05

3910

32906

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1527

10183

1.71

61.42

1.4

1.3

1.42

2.00

u/ml

1.80

490

2725

(3019060) Gas panel - Arterial blood

560

2743

2.17

58.02

5.3

4.7

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3905

33199

1.69

57.49

6.0

4.2

14.10

11.83

mm/h

15.32

3671

31138

(3017181) Myelocytes/Leukocytes in Blood

756

4150

1.96

57.38

5.2

4.3

0.76

0.93

1.61

233

1240

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

106

7.55

55.51

1.6

1.4

9.99

8.96

ug/l

0.74

106

(3002179) Metamyelocytes/Leukocytes in Blood

721

3945

1.96

55.10

5.0

4.1

0.57

0.73

1.66

221

1176

(3018010) Neutrophils/Leukocytes in Blood

2725

21420

1.57

53.82

8.7

6.3

57.80

57.44

0.92

2671

20439

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2871

22856

1.57

53.46

9.4

7.3

1.21

mmol/l

4.03

2419

19801

(3025159) Blasts/Leukocytes in Blood

718

4007

1.92

51.51

5.5

4.5

0.14

0.16

0.13

185

1013

(3021440) Promyelocytes/Leukocytes in Blood

711

3967

1.92

51.01

5.3

4.4

0.09

0.11

0.59

188

1059

(3013826) Glucose [Moles/volume] in Serum or Plasma

3272

27015

1.56

50.39

6.7

5.0

6.78

6.71

mmol/l

1.04

3143

25592

(3008152) Bicarbonate [Moles/volume] in Arterial blood

558

2875

2.05

50.29

8.0

6.7

24.52

24.48

mmol/l

0.09

531

2752

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

786

4566

1.85

49.64

4.6

3.4

—

(3037522) Nuclear Ab [Titer] in Serum

986

6141

1.75

49.22

1.5

1.3

444.39

522.31

titre

0.87

228

1262

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1918

14160

1.56

48.38

2.6

2.2

220.55

220.59

u/l

0.00

1799

13418

(3035350) Ketones [Presence] in Urine by Test strip

2978

24246

1.53

47.49

5.2

3.8

0.00

4.72

estimate

4.15

839

5167

(3009261) Glucose [Presence] in Urine by Test strip

2994

24409

1.53

47.41

5.2

3.8

0.04

0.07

estimate

0.17

779

4841

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2244

17208

1.53

47.30

4.8

3.7

35.71

84.72

ng/l

1.13

1645

11956

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1677

12097

1.57

46.40

2.7

2.3

2.93

2.77

mg/l

1.92

1483

10496

(3021601) Nitrite [Presence] in Urine by Test strip

2944

23978

1.52

46.34

5.1

3.7

0.00

estimate

0.06

834

5043

(40761536) Microorganisms panel - Urine sediment

650

3633

1.90

46.11

4.9

3.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

451

2263

2.09

43.43

5.1

3.9

48.40

47.30

0.42

443

2221

(3027273) Bicarbonate [Moles/volume] in Venous blood

421

2062

2.13

43.20

4.2

3.4

25.17

25.27

mmol/l

0.22

409

1981

(3018418) pH of Serum or Plasma

1833

13677

1.52

42.62

4.9

4.2

7.40

0.62

1420

9828

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1146

7692

1.63

42.32

2.1

1.9

—

(3017732) Neutrophils [#/volume] in Blood

912

5776

1.70

42.18

3.8

3.2

4.64

4.57

e9/l

0.11

828

5005

(3003458) Phosphate [Moles/volume] in Serum or Plasma

958

6151

1.68

42.08

7.3

6.1

1.05

1.04

mmol/l

0.98

895

5732

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1357

9508

1.58

41.77

1.9

1.7

20911960.86

32519221.74

pmol/l

0.47

1119

7980

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3937

34493

1.57

41.52

4.9

4.3

14.84

14.75

pmol/l

1.56

3629

31774

(3026008) Bacteria identified in Urine by Culture

1799

13468

1.51

40.71

3.7

3.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

628

3608

1.84

40.57

5.0

3.8

1.23

mmol/l

0.47

549

3138

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1150

7816

1.60

40.04

4.0

3.4

0.80

0.82

mmol/l

7.12

1088

7382

(3036481) Cortisol [Moles/volume] in Serum or Plasma

701

4216

1.77

38.76

2.5

2.3

363.82

380.12

nmol/l

1.15

651

3906

(3041096) Erythrocytes [Presence] in Urine by Automated

1737

13084

1.49

37.36

4.5

3.2

0.04

0.11

estimate

0.54

711

3964

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1780

13489

1.48

37.08

3.7

3.2

1727.60

1396.18

ng/l

1.50

1529

11634

(3012544) pH of Venous blood

769

4810

1.70

36.82

5.0

3.9

7.37

7.38

0.94

497

2766

(3019977) pH of Arterial blood

854

5500

1.66

36.58

8.4

7.9

7.41

7.42

0.66

520

3013

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2519

20446

1.45

36.51

8.3

6.6

1.20

1.21

mmol/l

3.93

2336

18955

(3021447) Carbon dioxide [Partial pressure] in Venous blood

755

4712

1.70

36.41

5.0

3.8

5.86

5.82

kpa

0.58

733

4576

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

190

708

2.75

35.78

1.1

1.3

—

11.80

u/ml

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

850

5501

1.65

35.64

8.4

7.9

5.09

5.10

kpa

0.03

808

5298

(3027801) Oxygen [Partial pressure] in Arterial blood

849

5499

1.65

35.47

8.4

7.9

11.35

12.48

kpa

11.29

803

5292

(3015171) Extractable nuclear Ab [Units/volume] in Serum

335

1627

2.13

35.00

1.3

1.2

0.19

0.90

u/ml

2.56

126

(3007164) IgA [Mass/volume] in Serum or Plasma

1252

8917

1.53

34.76

1.5

2.75

2.46

g/l

4.43

832

5558

(3002173) Hemoglobin [Mass/volume] in Arterial blood

728

4565

1.69

34.36

8.9

8.8

120.84

121.71

g/l

0.50

706

4463

(3003396) Base excess in Arterial blood by calculation

837

5453

1.64

34.04

8.3

7.9

1.24

0.92

mmol/l

1.56

659

4476

(3022948) Iron [Moles/volume] in Serum or Plasma

1142

8005

1.55

34.00

3.2

2.6

12.31

13.12

umol/l

3.09

1059

7494

(3016502) Oxygen saturation in Arterial blood

768

4906

1.66

33.73

8.5

8.2

95.72

95.53

0.41

728

4735

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

820

5352

1.63

33.02

2.1

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1956

15344

1.44

32.99

4.8

4.2

12.66

8.54

mg/mmol

2.61

1270

9717

(3024354) Oxygen [Partial pressure] in Venous blood

640

3919

1.72

32.88

4.6

3.2

4.44

4.54

kpa

0.73

616

3798

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

407

2179

1.94

32.44

5.8

5.0

1.72

1.60

1.42

384

2057

(3015736) pH of Urine

2358

19175

1.42

32.35

4.5

3.3

6.30

6.21

3.16

1395

10776

(3019309) Folate [Moles/volume] in Red Blood Cells

1068

7468

1.54

31.88

2.0

1.7

1243.51

1153.52

nmol/l

2.41

814

5712

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

548

3242

1.77

31.74

2.0

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

854

5687

1.60

31.54

2.0

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

313

1552

2.08

30.92

1.2

1.3

—

(3002032) Base excess in Venous blood by calculation

717

4599

1.65

30.79

5.1

3.9

1.93

1.87

mmol/l

0.17

620

3990

(3009508) Creatinine [Moles/volume] in Urine

2025

16144

1.41

30.52

4.0

3.4

7.37

7.73

mmol/l

3.18

1703

13676

(3000850) Epithelial cells [#/volume] in Urine

1395

10404

1.46

30.18

3.3

2.7

5.15

5.28

e6/l

0.12

1296

9496

(3020630) Protein [Mass/volume] in Serum or Plasma

617

3825

1.69

30.16

2.2

2.7

66.54

66.34

g/l

0.26

574

3505

(3012516) Albumin [Mass/volume] in Urine

1908

15079

1.42

30.10

3.9

3.5

68.63

48.79

mg/l

2.62

1247

9751

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1060

7485

1.52

30.01

3.2

2.6

2.32

2.31

g/l

0.21

977

6947

(3009445) Proteinase 3 Ab [Units/volume] in Serum

350

1827

1.98

29.99

1.4

1.6

3.00

17.34

iu/ml

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

936

6438

1.55

29.89

8.5

7.4

103.89

104.43

mmol/l

2.56

936

6433

(3021589) Normoblasts [#/volume] in Blood

2452

20268

1.39

29.62

16.6

11.3

0.00

e9/l

0.55

2171

16478

(1616796) Gas panel - Central venous blood

232

1039

2.29

29.58

4.9

3.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

295

1459

2.08

29.34

4.8

3.7

1.41

1.40

mmol/l

0.05

288

1434

(3023420) DNA double strand Ab [Units/volume] in Serum

327

1682

2.01

29.20

1.9

1.7

4.47

6.71

iu/ml

0.97

398

(3043409) Potassium [Moles/volume] in Arterial blood

252

1179

2.19

28.91

5.2

4.1

3.86

3.90

mmol/l

0.61

247

1167

(3007930) Methemoglobin/Hemoglobin.total in Blood

372

2008

1.92

28.87

6.1

5.2

0.88

0.08

349

1895

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

811

5439

1.58

28.84

3.9

4.5

237.54

243.41

u/l

0.63

767

5168

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

267

1283

2.14

28.63

2.2

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3379

29562

1.40

28.60

5.5

4.5

128.42

1390.70

e6/l

4.06

420

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

258

1225

2.16

28.52

1.6

1.7

1.16

1.19

g/l

0.84

247

1162

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

288

1427

2.08

28.49

1.7

1.5

5.22

7.35

iu/ml

0.13

272

(3004119) Hemoglobin [Mass/volume] in Venous blood

497

2951

1.76

28.31

4.5

3.2

125.46

129.80

g/l

4.16

484

2862

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1962

15705

1.40

28.25

3.8

3.3

34.07

35.52

u/l

0.27

1835

14868

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

353

1901

1.92

27.57

2.0

1.9

1.53

2.74

ug/l

1.51

321

1689

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

421

2404

1.82

27.35

4.0

2.8

0.66

0.61

2.47

421

2392

(3023520) Reticulocytes [#/volume] in Blood

640

4110

1.63

27.14

2.4

2.5

70.44

69.10

e9/l

0.45

510

3017

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

976

6911

1.51

26.93

3.3

2.6

21.48

22.92

2.60

895

6447

(3019150) Specific gravity of Urine by Refractometry

1404

10672

1.43

26.86

5.7

3.9

1.02

1.16

kg/l

0.50

963

7168

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

675

4409

1.61

26.69

2.5

2.3

0.20

0.21

g/l

2.46

626

4122

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1331

10036

1.44

26.56

2.1

1.8

1.16

1.30

mg/l

1.04

1058

7792

(3012494) Peanut IgE Ab [Units/volume] in Serum

6.13

26.23

1.1

3.12

1.79

u/ml

0.22

(3003329) Lymphocytes/Leukocytes in Synovial fluid

115

387

3.02

26.17

1.7

1.4

26.13

32.58

1.07

226

(3047181) Lactate [Moles/volume] in Blood

282

1431

2.03

26.14

6.1

5.7

1.25

1.30

mmol/l

0.40

246

1266

(3020779) Urea [Moles/volume] in Serum or Plasma

655

4273

1.61

25.99

10.0

7.5

10.85

10.00

mmol/l

2.06

629

4082

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

245

1184

2.12

25.89

1.7

0.24

g/l

0.16

230

1125

(3026493) Urate [Moles/volume] in Serum or Plasma

1560

12159

1.40

25.65

3.2

2.7

351.62

342.81

umol/l

2.51

1381

10786

(3021960) Folate [Moles/volume] in Serum or Plasma

1651

12995

1.40

25.61

1.8

1.7

18.66

20.09

nmol/l

3.89

1440

11066

(3019420) Tryptase [Mass/volume] in Serum or Plasma

180

3.98

25.03

1.6

1.7

7.38

10.81

ug/l

1.09

159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4426

41042

1.51

24.51

6.0

5.2

1.90

mu/l

0.07

4136

38097

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

180

786

2.34

24.37

1.1

1.3

891.67

440.65

titre

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

132

501

2.68

24.07

1.6

1.5

58.20

57.58

0.05

309

(3027231) Wheat IgE Ab [Units/volume] in Serum

8.20

23.49

1.1

1.0

0.68

0.30

u/ml

1.21

(3048689) Calprotectin [Mass/mass] in Stool

809

5702

1.50

22.44

3.1

2.4

146.81

134.12

ug/g

0.44

652

4554

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

117

4.57

22.37

3.3

2.7

154.00

97.01

au/ml

—

(3020961) Endomysium IgA Ab [Titer] in Serum

356

2058

1.78

22.12

1.2

1.1

67.50

131.87

titre

—

(3005719) IgG [Mass/volume] in Serum or Plasma

541

3509

1.60

21.81

3.3

2.8

11.04

10.65

g/l

1.05

506

3225

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2401

20385

1.33

21.75

2.9

2.4

74.23

77.03

nmol/l

5.37

2223

18551

(3027945) Reticulocytes/Erythrocytes in Blood

762

5342

1.50

21.64

2.3

2.5

1.88

1.79

1.34

678

4753

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1992

16472

1.34

21.60

4.2

3.4

—

1.48

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1903

15648

1.34

21.37

3.4

3.5

2.35

mmol/l

0.41

1746

14285

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

285

1558

1.88

21.23

2.7

2.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

210

1033

2.08

21.20

2.1

3.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

143

602

2.41

21.06

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

1043

2.06

20.67

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

204

1006

2.07

20.47

1.3

1.2

—

9.54

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1085

8214

1.40

20.35

1.4

1.3

27.89

30.75

iu/ml

0.41

378

2491

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

485

3120

1.61

20.18

3.9

3.8

5.17

5.15

kpa

0.25

465

2996

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

191

925

2.11

20.11

1.3

1.2

1.33

5.64

u/ml

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4669

44163

1.53

19.63

24.0

15.6

24.37

24.68

mg/l

0.26

4152

36397

(3009343) pH of Capillary blood

470

3023

1.61

19.56

3.8

7.41

7.42

0.92

410

2503

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

131

4.08

19.40

4.1

3.4

8.37

9.07

mg/l

0.30

104

(3012501) Base excess in Blood by calculation

192

946

2.07

19.32

5.8

4.0

3.02

2.53

mmol/l

1.20

141

626

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

8.37

19.25

1.0

4.38

0.41

u/ml

0.42

(3026782) Osmolality of Urine

1149

8865

1.38

19.07

3.8

2.9

509.67

538.62

mosm/kgh2o

4.67

1047

7792

(3030981) Hyaline casts [#/volume] in Urine by Automated count

563

3801

1.54

18.96

2.7

2.5

0.38

0.44

e6/l

0.40

534

3660

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1010

7644

1.40

18.79

1.3

10.08

11.99

u/ml

0.43

443

2996

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

374

2294

1.68

18.77

1.7

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

228

1210

1.92

18.61

1.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

872

2.09

18.58

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

772

5586

1.45

18.45

2.1

1.7

1.70

1.47

8.07

654

4914

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

223

1179

1.93

18.41

1.4

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

202

1034

1.99

18.31

2.8

3.0

31.06

35.21

umol/l

1.75

181

940

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

157

732

2.18

18.25

1.3

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4734

45019

1.54

18.22

26.8

18.5

139.31

139.70

mmol/l

21.72

4671

44189

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

228

1219

1.91

18.20

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

183

909

2.05

18.04

1.3

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

285

1642

1.78

17.91

2.5

2.3

545.71

656.92

ug/l

0.26

272

1563

(3039000) Anion gap in Blood by calculation

194

988

2.00

17.85

7.1

6.7

11.29

11.24

mmol/l

0.06

174

886

(3018572) Chloride [Moles/volume] in Blood

194

989

2.00

17.80

7.1

6.7

104.63

105.21

mmol/l

0.91

174

887

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

413

2638

1.61

17.65

3.6

1.71

1.82

mmol/l

0.19

305

1945

(3023103) Potassium [Moles/volume] in Serum or Plasma

4738

45125

1.52

17.44

26.9

18.7

3.98

3.97

mmol/l

1.53

4673

44213

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2490

21654

1.29

17.30

3.8

3.1

139.80

128.09

ug/l

1.03

2326

20297

(3044889) 12 lead EKG panel

3469

31481

1.30

17.25

4.9

4.0

0.29

6438.37

—

(3004616) Nuclear Ab [Presence] in Serum

115

481

2.42

17.25

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

524

3591

1.51

16.38

3.6

3.0

208.24

195.79

ng/l

0.19

482

3288

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3392

30804

1.29

16.14

4.2

3.3

56.84

47.65

u/l

5.82

3192

29021

(3028026) IgM [Mass/volume] in Serum or Plasma

418

2737

1.57

16.07

2.0

1.32

1.31

g/l

0.04

385

2515

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

790

2.06

16.07

1.5

1.6

—

(3034891) Synovial lining cells/cells in Synovial fluid

200

3.18

15.97

1.5

1.4

4.13

3.05

0.27

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

222

1231

1.84

15.85

1.4

1.2

26.65

36.46

u/ml

0.30

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2317

20110

1.27

15.81

2.3

2.1

94.14

95.50

pmol/l

0.75

1366

10768

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2472

21637

1.27

15.69

3.3

2.8

—

estimate

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

489

3340

1.51

15.51

1.5

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

6.69

15.29

1.1

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

208

1144

1.85

15.25

1.4

1.3

8.92

5.73

u/ml

0.24

106

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

526

3675

1.48

14.92

3.0

2.7

63.30

67.06

ml/min/173m2

1.28

248

1536

(3042631) Mycobacterium sp identified in Specimen

127

592

2.17

14.84

2.1

2.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

954

1.92

14.81

5.7

5.8

389.77

2164.49

iu/ml

0.58

140

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

261

1554

1.72

14.64

2.1

3.7

49.30

56.29

mg/l

0.26

195

1332

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

543

3835

1.46

14.56

2.7

2.3

6.33

7.92

ug/l

1.01

490

3393

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

438

2965

1.52

14.47

10.5

10.3

0.66

0.63

0.74

431

2943

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

123

573

2.17

14.40

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

260

1555

1.71

14.35

2.1

3.7

65.47

89.75

mg/l

0.31

195

1335

(3017143) Hepatitis C virus Ab [Presence] in Serum

707

5253

1.40

14.33

1.8

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

450

3072

1.51

14.29

10.3

10.0

1.45

1.31

2.87

441

3052

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

204

1140

1.82

14.23

1.9

2.0

10.87

11.40

mg/l

0.33

190

1057

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

331

5034

0.63

14.18

1.8

2.0

3.61

3.51

ratio

0.64

249

3880

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

204

1144

1.81

14.08

1.4

1.3

12.30

6.78

u/ml

0.27

170

(46235355) HIV 1 and 2 tests - Meaningful Use set

1042

8249

1.33

14.06

2.0

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

231

1349

1.75

13.89

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

362

2372

1.57

13.86

1.4

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

412

2780

1.52

13.82

10.9

10.2

15.95

16.05

0.30

391

2682

(3018677) aPTT in Platelet poor plasma by Coagulation assay

922

7196

1.34

13.67

2.7

2.1

29.84

29.71

0.22

894

7012

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

121

578

2.12

13.33

1.5

—

(44813793) Dust mix specific IgE antibody measurement

262

2.69

13.29

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

257

1566

1.67

13.25

2.5

2.2

4906.17

6033.11

u/l

0.23

617

(3020874) Milk IgE Ab [Units/volume] in Serum

213

2.89

13.19

1.1

1.0

1.11

0.74

u/ml

0.22

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

104

471

2.23

13.09

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

577

4206

1.42

13.00

8.6

8.0

1.35

1.32

mmol/l

0.28

565

4121

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

230

1371

1.71

12.87

1.9

3.5

2.05

2.92

ratio

0.86

135

799

(3006184) Hemoglobin [Mass/volume] in Capillary blood

198

1132

1.78

12.84

2.8

2.2

129.10

129.48

g/l

0.08

174

873

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

356

2.41

12.81

1.3

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1765

15098

1.25

12.78

4.0

3.4

40.49

89.42

e6/l

3.22

1476

11544

(3010726) Horse dander IgE Ab [Units/volume] in Serum

131

656

2.02

12.74

1.1

2.21

1.04

u/ml

0.68

293

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

3.80

12.42

2.1

1.7

22.46

222.43

au/ml

—

(3023419) Bacteria identified in Sputum by Culture

119

581

2.07

12.40

1.8

2.5

—

(3000012) Reticulocyte production index

134

686

1.98

12.26

2.1

1.9

0.98

0.89

0.93

101

477

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

481

3437

1.44

12.08

4.8

3.9

101.60

90.65

ng/l

1.41

400

2959

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

666

5040

1.37

11.97

10.9

6.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

209

2.79

11.87

1.6

186.24

136.66

umol/l

0.30

111

(44816559) Phosphatidylethanol [Mass/volume] in Blood

302

1971

1.56

11.79

2.2

1.7

0.43

0.30

mg/l

2.83

184

915

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

985

7927

1.30

11.55

1.8

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

292

1905

1.56

11.42

2.0

1.9

37.76

39.59

u/l

0.84

268

1693

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4384

41740

1.31

11.31

7.7

6.3

40.23

39.26

mmol/mol

9.79

4112

39241

(3043238) Trisomy 21 risk [Likelihood] in Fetus

854

0.24

11.22

1.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

210

2.73

11.21

1.3

1.1

—

(3004451) EKG impression Narrative

256

2.56

11.21

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

178

1029

1.76

11.16

5.0

4.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

240

3716

0.63

11.06

1.5

1.7

3.57

3.49

mmol/l

0.49

163

2553

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

888

7091

1.30

10.99

1.8

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

142

3.12

10.96

2.4

2.1

9.03

9.30

mg/l

0.14

123

(3000991) Gas panel - Venous blood

544

4049

1.38

10.80

10.5

9.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

226

1408

1.63

10.74

3.8

3.2

1.64

1.54

mg/l

1.04

201

1296

(3005033) Fetal Nuchal fold Thickness US

823

0.25

10.57

1.4

1.5

1.41

1.28

0.32

573

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

282

2.43

10.55

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

838

0.26

10.55

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

229

2.59

10.51

1.1

1663.93

1389.21

miu/ml

1.00

229

(3030467) Casts [#/volume] in Urine by Automated count

1519

13013

1.24

10.35

3.9

3.2

0.37

0.44

e6/l

0.85

1251

9559

(3000475) Leukocytes [#/volume] in Synovial fluid

187

1121

1.69

10.32

1.9

1.6

12506.22

12321.71

e6/l

0.03

152

783

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

208

1283

1.65

10.29

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

319

2172

1.50

10.26

1.6

1.7

1.55

1.52

g/l

0.20

267

1884

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

305

2.35

10.20

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4442

42503

1.30

10.05

5.8

5.1

6.03

5.94

mmol/l

4.58

4095

39255

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

837

1.79

10.03

1.1

3.34

1.74

u/ml

0.80

424

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

302

2.34

9.97

1.3

3.87

0.78

u/ml

1.04

160

(3014133) Dog dander IgE Ab [Units/volume] in Serum

112

582

1.94

9.90

1.1

4.88

1.85

u/ml

1.71

260

(3010144) Erythrocytes [#/volume] in Synovial fluid

396

2.14

9.68

1.6

1.3

61489.25

118623.37

e6/l

0.53

265

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

175

1052

1.69

9.58

2.4

139.13

100.03

ug/min

0.38

648

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

987

0.35

9.53

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

999

0.36

9.48

1.4

1.5

1.20

1.19

ratio

0.03

592

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

999

0.36

9.48

1.4

1.5

0.97

0.95

ratio

0.17

588

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

998

0.36

9.46

1.4

1.5

1.07

1.13

ratio

0.20

587

(3003888) Timothy IgE Ab [Units/volume] in Serum

128

707

1.83

9.40

1.1

4.45

4.07

u/ml

0.10

348

(3024980) IgG subclass 4 [Mass/volume] in Serum

136

768

1.79

9.30

1.5

1.6

0.76

0.80

g/l

0.15

597

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

268

2.37

9.29

1.3

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4845

47034

1.40

9.28

29.8

20.4

79.81

78.17

umol/l

2.07

4814

46505

(3028707) Methadone [Presence] in Urine by Screen method

129

721

1.81

9.13

3.9

2.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1064

8874

1.25

9.08

2.9

3.0

2.47

2.45

mmol/l

3.48

980

7959

(3028192) IgG subclass 2 [Mass/volume] in Serum

481

1.99

9.08

1.4

1.3

2.92

3.00

g/l

0.18

354

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

158

942

1.70

8.94

1.7

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

212

2.52

8.93

1.0

0.72

0.43

u/ml

0.75

(3037756) Immunofixation for Serum or Plasma

156

931

1.70

8.81

1.3

1.7

—

(4062490) Immunoglobulin typing, IgG

473

1.98

8.79

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

481

1.97

8.73

1.4

1.3

0.49

0.42

g/l

0.82

353

(3027135) IgG subclass 1 [Mass/volume] in Serum

482

1.97

8.68

1.4

1.3

7.08

6.97

g/l

0.08

351

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.76

8.58

2.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

478

1.96

8.54

1.8

2.0

5.92

6.60

umol/l

0.20

340

(3018001) Oat IgE Ab [Units/volume] in Serum

10.03

8.51

1.0

0.30

0.02

u/ml

—

(3010375) cycloSPORINE [Mass/volume] in Blood

176

2.63

8.50

28.7

26.5

114.70

114.68

ug/l

0.00

140

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

307

2.20

8.35

2.6

2.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

129

743

1.75

8.29

3.8

3.4

1.31

1.68

0.42

119

656

(40768797) Stomach Pathology biopsy report

772

6267

1.27

8.24

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

739

1.75

8.17

3.0

2.8

7172.00

2660.72

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

384

2.05

8.10

2.1

1.4

1.23

1.26

promille

0.06

300

(3000570) Elastase.pancreatic [Mass/mass] in Stool

207

1357

1.55

8.01

1.4

270.97

274.15

ug/g

0.07

127

783

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

109

3.04

7.99

1.2

1.4

36.32

33.41

0.15

(36660697) Celiac disease serology panel - Serum

463

3547

1.33

7.61

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

8.02

7.58

1.0

0.46

1.74

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4800

46707

1.33

7.45

16.4

11.8

26.51

26.68

u/l

0.23

4697

45424

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

163

1031

1.60

7.39

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

7.64

7.37

1.0

0.03

0.04

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

202

2.39

7.33

1.1

4.20

3.64

iu/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

111

636

1.76

7.31

7.2

6.6

11.64

11.91

mg/l

0.23

105

589

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

173

1114

1.57

7.28

1.1

1.88

8.27

eliau/ml

—

142

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

9.35

7.27

1.0

1.1

2.93

2.20

u/ml

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

371

2769

1.37

7.25

5.3

4.0

24.06

24.21

mmol/l

0.44

363

2741

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1053

8963

1.22

7.25

5.0

3.9

335.69

528.48

ng/l

0.85

817

7000

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

227

1554

1.48

7.20

3.5

3.3

0.33

iu/ml

0.03

130

843

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2103

19046

1.17

7.20

2.1

1.9

1.41

1.36

mmol/l

1.90

1704

16061

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

7.29

7.17

1.0

0.06

0.03

u/ml

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

186

2.43

7.15

1.1

1.2

15.40

12.50

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

117

686

1.72

7.12

1.1

0.72

0.80

u/ml

0.09

261

(3018095) Leukocytes [#/volume] in Urine

1914

17215

1.18

7.10

4.5

3.9

93.38

97.26

e6/l

0.08

1526

12163

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

163

2.53

7.07

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

200

2.36

7.02

43.8

37.9

7.22

7.47

ug/l

0.37

181

(3003181) Sodium [Moles/volume] in Urine

133

817

1.64

6.82

1.4

60.77

62.92

mmol/l

0.24

653

(3035285) Chloride [Moles/volume] in Venous blood

517

1.81

6.81

3.0

2.2

106.69

105.38

mmol/l

1.70

510

(3041354) Potassium [Moles/volume] in Venous blood

517

1.81

6.81

3.0

2.2

4.13

4.08

mmol/l

0.49

510

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

120

2.76

6.78

1.1

1.0

9.91

10.04

u/ml

0.01

(4198724) Urine methamphetamine measurement

180

2.40

6.67

2.6

2.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

174

2.43

6.66

3.9

3.6

1.06

1.12

0.11

174

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

233

1632

1.45

6.60

2.1

1.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

5.47

6.59

1.1

1.0

0.01

0.06

u/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

156

1005

1.57

6.59

1.6

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

169

2.44

6.58

1.5

1.9

0.52

1.09

u/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

250

1776

1.43

6.56

2.2

1.9

—

(3033099) Centromere Ab [Titer] in Serum

3.34

6.54

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

466

1.84

6.52

1.3

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

504

1.80

6.45

3.1

2.3

1.21

1.20

mmol/l

1.36

497

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

308

2275

1.38

6.45

2.5

2.4

—

(44806420) Estimation of glomerular filtration rate

492

1.80

6.35

2.8

2.3

—

(3011412) CD3 cells [#/volume] in Blood

393

1.90

6.28

2.4

2.5

995.48

1116.62

e6/l

0.84

348

(3026692) Albumin [Mass/volume] in Peritoneal fluid

143

2.53

6.26

1.3

1.5

14.72

12.66

g/l

0.60

107

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

283

2.06

6.26

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

250

2.13

6.24

2.2

2.5

97.35

95.19

0.16

243

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4307

41538

1.21

6.22

4.9

4.2

1.35

1.29

mmol/l

6.96

3961

38470

(44790049) Parainfluenza type 3 nucleic acid detection

101

596

1.71

6.07

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

101

596

1.71

6.07

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

101

596

1.71

6.07

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

101

596

1.71

6.07

1.6

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

198

1373

1.46

5.94

3.0

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

147

2206

0.66

5.94

1.8

1.7

—

(3011985) Renin [Units/volume] in Plasma

110

669

1.66

5.92

1.3

1.4

89.83

52.86

mu/l

0.55

103

608

(21494890) Protein electrophoresis panel - 24 hour Urine

452

1.80

5.91

1.5

2.2

—

(21494755) Public health laboratory ask at order entry panel

322

4217

0.75

5.91

1.3

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

236

2.13

5.90

1.1

52.64

29.25

u/l

0.58

214

(3016879) Cocaine [Presence] in Urine

227

1620

1.42

5.84

2.9

2.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

930

1.55

5.84

1.4

1.2

72.27

37.85

u/ml

0.93

(3040151) Glucose [Moles/volume] in Capillary blood

521

1.74

5.81

4.4

18.0

7.78

7.29

mmol/l

0.63

441

(3021387) Prolactin [Units/volume] in Serum or Plasma

225

1606

1.42

5.79

1.8

1.7

345.17

295.82

mu/l

0.68

205

1463

(3008295) Osmolality of Serum or Plasma

507

1.75

5.78

1.4

277.74

278.35

mosm/kgh2o

0.09

394

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

245

2.09

5.76

1.3

1.5

4.75

6.77

u/l

1.76

211

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

279

2.02

5.74

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

363

1.88

5.72

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

363

1.88

5.72

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

363

1.88

5.72

1.3

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

1860

1.38

5.64

1.7

2.4

4.02

3.69

g/l

1.24

230

1712

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

1861

1.38

5.62

1.7

2.4

4.34

4.21

g/l

1.28

230

1713

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

1862

1.38

5.61

1.7

2.4

7.57

7.37

g/l

1.17

230

1714

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

352

1.89

5.58

1.3

1.2

—

(40758558) Short blood count panel - Blood

1544

13861

1.16

5.55

7.8

6.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.51

5.55

1.0

0.80

0.01

u/ml

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

646

5373

1.23

5.50

2.7

2.8

10.18

8.40

umol/l

0.81

536

4733

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

824

9597

0.83

5.43

3.0

3.3

0.75

0.77

ug/l

0.16

546

6330

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3869

37106

1.16

5.35

27.2

19.4

13.88

13.61

27.13

3832

36610

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

239

2.06

5.35

1.1

121.01

91.57

u/l

0.57

216

(3009466) Valproate [Moles/volume] in Serum or Plasma

102

626

1.64

5.34

5.5

387.08

358.74

umol/l

1.31

548

(3020123) Porphyrins [Interpretation] in Serum or Plasma

7.87

5.34

1.2

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

164

1121

1.48

5.34

1.3

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4508

43801

1.21

5.29

5.9

5.1

4.52

4.61

mmol/l

8.39

4204

41188

(3021879) Hepatitis B virus core Ab [Presence] in Serum

444

3558

1.27

5.25

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

234

2.06

5.25

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

102

2.66

5.23

2.6

2.3

102.00

318.11

ug/l

0.34

102

(3034770) Mitochondria Ab [Titer] in Serum

190

1344

1.43

5.18

1.2

776.00

1020.54

titre

—

(3011288) Drugs identified in Urine by Screen method Nominal

171

1186

1.46

5.18

3.8

3.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

192

1362

1.43

5.15

1.3

1.2

115.48

117.08

titre

0.01

130

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

100

618

1.63

5.11

1.2

1.3

328.60

354.06

pmol/l

0.17

525

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

429

1.76

5.09

1.4

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

228

1670

1.38

5.09

1.6

18.82

16.94

u/ml

0.19

414

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

8.35

5.05

1.0

2.36

0.01

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

201

1445

1.41

5.02

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4561

44407

1.21

5.00

6.4

5.7

2.64

2.70

mmol/l

4.68

4239

41591

(3023430) Cat dander IgE Ab [Units/volume] in Serum

547

1.66

4.92

1.2

1.1

8.71

3.10

u/ml

1.12

211

(3028300) Cannabinoids [Presence] in Urine

237

1759

1.36

4.89

2.8

2.1

—

(3027008) Opiates [Presence] in Urine

236

1752

1.36

4.86

2.8

2.0

—

(3022145) Colonoscopy Study observation

617

5174

1.22

4.85

1.5

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

256

1.96

4.81

1.1

1.2

1.05

1.06

ratio

0.22

203

(3014765) Yersinia sp identified in Stool by Organism specific culture

162

1129

1.45

4.81

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

234

1741

1.36

4.76

2.8

2.1

—

(3016750) Collection duration of Urine

258

1.95

4.71

2.3

2.1

481.37

492.62

min

0.34

190

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

136

920

1.49

4.70

3.0

1.9

0.88

0.86

nmol/l

0.09

117

787

(42529406) Shigella sp [Presence] in Stool by Culture

162

1135

1.44

4.69

1.3

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4474

43540

1.19

4.62

5.6

5.0

1.41

1.45

mmol/l

6.25

4145

40700

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

103

659

1.57

4.60

1.1

1.56

1.53

g/l

0.37

603

(3011397) Hemoglobin [Presence] in Urine by Test strip

1229

10980

1.16

4.58

5.0

3.6

0.18

0.02

127

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

566

1.62

4.57

1.5

1.3

—

nmol/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

445

1.70

4.52

1.1

1.2

73.54

63.51

u/l

0.30

395

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

106

687

1.55

4.49

1.4

1.3

0.88

0.33

nmol/l

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

123

2.37

4.47

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

123

2.37

4.47

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

123

2.37

4.47

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

123

2.37

4.47

1.1

1.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

594

1.59

4.44

2.5

2.6

13.32

13.16

1.09

588

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

136

2.29

4.44

2.4

2.0

1.95

1.70

ratio

0.25

131

(3036670) Protein [Mass/volume] in Synovial fluid

136

2.29

4.44

1.5

1.2

38.79

39.58

g/l

0.10

(3006442) Creatine [Moles/volume] in Serum or Plasma

278

1.88

4.44

1.5

75.81

84.08

umol/l

1.10

278

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

114

754

1.52

4.41

1.1

2.07

0.97

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

124

2.35

4.40

1.4

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1736

1.34

4.30

1.8

2.5

2.86

2.92

g/l

0.41

206

1589

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

355

1.76

4.26

1.1

1.3

2.03

2.09

mmol/l

0.29

331

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

172

2.10

4.21

2.8

2.4

124.47

151.36

nmol/l

1.06

154

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

2.16

4.17

1.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

228

1728

1.33

4.15

2.7

2.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

180

2.06

4.14

1.2

1.1

219.74

183.22

iu/ml

0.34

180

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

280

2191

1.29

4.06

1.2

1.1

0.88

1.98

u/ml

—

(3017704) Immunofixation for Urine

244

1.89

4.05

1.2

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

369

1.72

4.02

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

121

828

1.47

4.01

1.6

1.8

—

(3004775) Volume in Urine collected for unspecified duration

355

1.73

3.99

2.4

2.2

681.14

628.58

0.38

231

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1024

0.60

3.95

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

211

1597

1.33

3.90

1.6

2.5

9.96

10.24

g/l

0.45

186

1433

(3023487) Leukocytes [#/volume] in Peritoneal fluid

185

2.01

3.87

1.9

2.1

697.75

4882.60

e6/l

0.48

126

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

349

2827

1.25

3.83

1.3

38.23

53.70

au/ml

1.26

194

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

1.92

3.81

1.0

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

2.19

3.79

1.6

1.2

0.32

0.30

g/l

0.44

111

(3017509) Phencyclidine [Presence] in Urine

3.69

3.79

1.0

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

351

2852

1.25

3.76

3.3

3.5

4.36

4.50

pmol/l

1.93

315

2559

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

447

1.62

3.72

1.0

1.1

—

34.94

—

(3036782) Glucose [Moles/volume] in Pleural fluid

494

1.59

3.71

1.4

6.51

6.25

mmol/l

0.32

464

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.12

3.64

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

129

2.18

3.63

1.3

1.2

28.53

12.03

pmol/l

0.88

(3023199) Leukocytes [#/volume] in Pleural fluid

593

1.53

3.62

1.6

1.4

2572.74

3820.50

e6/l

0.35

414

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

197

1.94

3.61

1.0

1.1

100.30

91.79

0.89

155

(3000060) B lymphocytes [#/volume] in Blood

110

2.28

3.61

2.6

2.3

0.09

0.16

e9/l

1.34

(3014148) Varicella zoster virus Ab [Titer] in Serum

602

1.52

3.59

1.1

—

(3022313) Gas panel - Capillary blood

268

2124

1.28

3.56

4.0

3.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.57

3.54

1.2

1.3

83.14

478.63

u/l

0.48

(3016038) Potassium [Moles/volume] in Urine

315

1.72

3.54

1.0

1.2

31.52

36.54

mmol/l

1.19

277

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

264

1.79

3.51

2.1

2.6

475.92

492.64

e6/l

0.10

214

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

742

6508

1.16

3.50

1.6

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.16

3.50

3.1

3.6

—

(4034850) Laboratory test

181

1372

1.33

3.36

10.3

9.5

—

(3007461) Platelets [#/volume] in Blood

4895

48233

1.23

3.33

35.5

23.8

256.13

249.48

e9/l

9.39

4844

47316

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

509

1.54

3.30

1.1

1.0

0.21

0.08

u/ml

0.71

138

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

3.43

3.30

3.2

1.6

52.29

56.64

—

(3035941) MCH [Entitic mass]

4895

48240

1.23

3.28

35.3

23.7

30.39

30.34

1.18

4858

47756

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.93

3.28

2.5

1.9

—

(3044007) Cell count panel - Peritoneal fluid

169

1.96

3.28

2.2

1.9

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4895

48241

1.23

3.27

35.4

23.7

91.37

91.08

4.37

4858

47757

(4024509) Urine culture

260

2076

1.27

3.27

2.1

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

373

3099

1.22

3.27

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

506

0.49

3.26

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4895

48246

1.22

3.24

36.1

24.3

40.01

40.91

4.21

4855

47738

(3026361) Erythrocytes [#/volume] in Blood

4895

48246

1.22

3.24

35.5

23.8

4.44

4.50

e12/l

15.19

4837

47193

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

520

1.53

3.23

2.2

2.0

23.57

22.57

mg/l

0.09

178

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

150

2.01

3.19

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

123

2.12

3.19

1.3

28.11

24.57

g/l

0.42

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

427

1.58

3.16

2.7

2.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

4895

48257

1.22

3.16

35.8

23.9

133.77

135.61

g/l

14.19

4859

47780

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

2.05

3.16

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

580

1.49

3.14

2.7

2.4

1.17

1.25

g/24h

0.14

338

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

124

2.10

3.13

1.1

97.31

89.81

1.01

(3010813) Leukocytes [#/volume] in Blood

4894

48250

1.22

3.13

35.5

23.8

7.13

6.72

e9/l

25.52

4834

47188

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

119

1633

0.72

3.10

1.1

0.61

0.64

ratio

—

213

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

351

1.63

3.10

1.2

1.3

16.19

13.89

u/l

0.31

321

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.29

3.09

1.2

1.3

1.29

1.64

mmol/l

0.63

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

159

1.96

3.08

1.7

1.9

2546.67

5333.12

e6/l

0.78

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

114

815

1.41

3.08

1.9

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

561

1.49

3.02

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

258

2081

1.25

3.01

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

554

1.49

2.99

1.4

—

(3024263) Appearance of Synovial fluid

233

1.77

2.99

1.8

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

241

1.75

2.97

1.2

1.6

8.65

6.41

u/l

0.33

195

(3028433) Virus identified in Specimen by Culture

127

2.05

2.96

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

107

2.15

2.96

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

492

4236

1.18

2.95

1.9

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

183

1419

1.30

2.94

2.9

2.6

3.61

3.55

g/l

0.22

171

1355

(3027456) Digoxin [Moles/volume] in Serum or Plasma

119

866

1.38

2.92

3.2

0.84

0.82

nmol/l

0.16

690

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.83

2.91

1.5

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

140

1047

1.35

2.90

1.3

3.85

3.79

mmol/l

0.32

132

987

(3027923) C peptide [Moles/volume] in Serum or Plasma

273

1.69

2.90

1.3

1.4

1.18

1.23

nmol/l

0.13

195

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

108

2.13

2.90

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.37

2.89

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

860

0.64

2.88

1.4

1.6

—

(3017569) Oxygen content in Arterial blood

289

1.67

2.87

3.1

2.3

16.50

16.30

0.15

289

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

470

1.52

2.87

1.1

—

3.76

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

367

3088

1.20

2.86

2.6

2.4

15.09

21.21

au/ml

1.30

321

(3006653) Thiamine [Moles/volume] in Blood

244

1.73

2.86

1.4

1.2

140.01

137.20

nmol/l

0.15

244

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

552

1.47

2.85

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

200

1.81

2.84

1.0

0.47

0.23

u/ml

0.43

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.29

2.83

1.3

0.26

2.30

mmol/l

1.43

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

275

1.68

2.83

2.3

2.8

203.95

226.37

e6/l

0.38

235

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

123

2.04

2.81

1.1

1.2

100.50

88.13

1.55

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.23

2.79

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

217

1.76

2.75

3.3

3.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

152

1.91

2.74

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

524

1.48

2.74

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.31

2.74

1.2

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2900

27816

1.10

2.73

3.1

3.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

111

2.08

2.72

1.0

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

174

1.84

2.71

2.7

2.1

31.06

30.66

0.05

174

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

6.01

2.69

1.0

0.48

0.03

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

171

1333

1.29

2.67

1.4

10.12

9.89

u/l

0.09

138

1080

(3044640) Blood type and Crossmatch panel - Blood

1611

15052

1.10

2.65

3.0

2.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

528

1.47

2.65

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

126

1.99

2.65

1.2

118.10

104.31

1.46

118

(3045788) Cell count panel - Pleural fluid

488

1.48

2.63

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

529

1.46

2.63

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

604

1.43

2.62

1.3

7.01

7.29

mmol/l

0.45

548

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

154

1191

1.30

2.56

1.3

723.27

551.58

mg/l

0.56

147

1131

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

205

1644

1.26

2.56

4.1

3.9

24.72

24.83

mmol/l

0.16

188

1517

(3017354) Segmented neutrophils/Leukocytes in Blood

491

1.47

2.56

2.6

3.3

53.25

57.92

0.91

417

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

185

1466

1.27

2.55

2.6

2.3

91.69

91.84

0.03

179

1419

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

339

2866

1.20

2.54

10.9

10.0

24.04

24.26

mmol/l

0.63

326

2813

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.46

2.54

1.0

0.01

0.05

u/ml

—

(40768446) Kidney Pathology biopsy report

164

1.83

2.52

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

795

1.37

2.52

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

584

1.43

2.51

1.4

1.3

0.20

0.21

nmol/l

0.17

465

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

493

1.47

2.51

2.3

1.6

759.21

361.84

mu/l

1.73

382

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

277

1.63

2.51

1.4

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.23

2.51

1.0

1.1

—

383.44

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.23

2.51

1.0

1.1

0.07

0.03

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

523

0.57

2.48

1.5

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.98

2.48

2.5

2.4

0.73

0.51

u/field

0.23

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.32

2.48

1.2

1.3

87.75

98.28

0.53

(3036525) Urea [Moles/time] in 24 hour Urine

3.81

2.46

4.1

3.4

—

(3045414) Leukocytes [Presence] in Urine

504

4416

1.16

2.45

2.2

2.1

0.03

0.01

estimate

0.25

137

937

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

1.90

2.45

1.0

1.1

—

(3008898) HLA-B27 [Presence]

191

1529

1.26

2.44

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

2.41

0.0

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

708

1.38

2.40

1.6

1.5

60.65

59.52

ug/l

0.09

708

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

449

1.48

2.40

1.3

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

515

1.44

2.39

1.6

1.4

34504.38

71783.49

e6/l

0.97

283

(3023323) Follitropin [Units/volume] in Serum or Plasma

258

2139

1.22

2.39

1.3

1.4

25.79

27.50

iu/l

0.35

215

1836

(3016228) CD19 cells/cells in Blood

175

1.78

2.37

2.5

2.0

6.81

8.78

0.79

169

(3000093) Morphology [Interpretation] in Blood Narrative

426

1.48

2.36

1.3

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

206

1.70

2.33

1.2

1.3

162.56

164.67

mmol/24h

0.04

206

(3029634) Reagin Ab [Titer] in Serum by VDRL

628

1.39

2.31

1.8

2.2

—

5.79

—

(3045424) Erythrocytes [Presence] in Urine

269

2249

1.21

2.30

2.1

0.00

0.37

estimate

0.54

725

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

197

1597

1.24

2.27

2.2

2.5

0.70

0.97

g/l

0.48

157

1371

(3009015) Lactate [Moles/volume] in Synovial fluid

2.56

2.27

1.4

1.3

7.49

5.56

mmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.56

2.27

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

262

1.61

2.26

2.8

39.49

40.28

0.15

146

(3046861) Legionella sp Ag [Presence] in Urine

3.11

2.22

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

2.00

2.20

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

120

919

1.31

2.20

1.4

1.2

255.10

277.02

u/ml

0.36

581

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

273

1.58

2.16

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

739

1.35

2.16

1.7

1.3

—

(3042733) HLA Ab [Presence] in Serum

151

1.79

2.15

4.3

4.8

—

(40762365) Oxygen content in Arterial blood by calculation

2.17

2.14

2.8

2.3

14.84

14.95

ml/dl

0.05

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.78

2.13

1.9

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.37

2.12

1.0

1.1

—

(1002224) Polysomnography panel

182

2225

0.81

2.07

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

678

7479

0.89

2.06

3.8

3.1

3.78

2.28

e6/l

1.24

380

3667

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.00

2.04

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.63

2.00

1.1

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

103

784

1.32

2.00

1.9

5.13

5.02

mmol/24h

0.12

696

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

480

5395

0.88

1.99

5.1

4.9

31.30

32.26

1.16

327

3628

(3020911) Cortisol [Moles/time] in 24 hour Urine

148

1.76

1.98

1.3

1.4

1129.85

147.88

nmol/24h

0.44

148

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

163

1.72

1.97

2.4

2.0

51.89

61.12

ug/l

0.41

158

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

665

1.34

1.96

1.1

120.19

113.81

1.33

606

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

165

1337

1.24

1.96

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

491

4369

1.14

1.95

2.1

2.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

202

1.64

1.95

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

249

1.57

1.94

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

305

1.51

1.94

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

2.57

1.94

1.4

2.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.97

1.93

1.3

1.1

—

(3000330) Specific gravity of Urine by Test strip

269

2296

1.18

1.88

4.9

3.2

1.02

ratio

0.14

255

2064

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.31

1.87

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

2.03

1.85

1.4

2.0

2.93

2.85

mmol/l

0.03

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

159

1.70

1.85

1.5

1.4

15.59

15.28

pmol/l

0.10

136

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.94

1.84

6.7

6.9

10.70

10.49

0.14

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.92

1.79

1.1

—

(40768806) Pleura Pathology biopsy report

513

1.37

1.77

1.5

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

363

0.58

1.77

5.8

2.7

43.26

32.00

mg/l

0.42

258

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

130

1039

1.26

1.77

1.4

39.33

27.05

e6/l

0.20

108

761

(3012441) Differential panel - Pleural fluid

506

1.37

1.74

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.34

1.74

1.0

1.1

0.08

0.07

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

338

1.45

1.74

1.1

33.16

45.43

mg/l

2.19

280

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

1.72

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.92

1.72

1.3

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.13

1.71

1.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

373

1.43

1.70

1.2

100.70

105.64

pmol/l

0.36

373

(3038071) Oxygen [Partial pressure] in Mixed venous blood

118

1.78

1.69

8.5

7.0

5.61

5.41

kpa

0.17

118

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.66

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

115

914

1.26

1.66

1.7

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

105

1322

0.79

1.62

1.1

—

(4195642) Thrombophilia screening test

661

1.31

1.62

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.57

1.61

1.0

1.1

0.06

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

166

1.63

1.61

1.6

3776.00

2931.61

titre

—

(3003327) Ova and parasites identified in Stool by Light microscopy

178

1489

1.20

1.60

1.6

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

128

1.72

1.60

2.0

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

680

1.30

1.59

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

2.50

1.59

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

1.59

1.2

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

2.00

1.59

3.1

7.0

8.31

8.07

mmol/l

0.09

(3036048) Francisella tularensis Ab [Titer] in Serum

106

1.80

1.58

1.3

1.2

—

166.67

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

3.00

1.58

1.5

1.3

1.63

1.79

mg/l

—

(3036489) Thrombin time

207

1760

1.18

1.57

2.5

2.1

20.55

21.07

0.89

172

1554

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.20

1.56

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.20

1.56

1.3

1.2

—

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.20

1.56

1.3

1.2

—

mmol/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

108

860

1.26

1.55

1.8

1.4

136.93

152.75

au/ml

0.53

249

(44806071) Cardiolipin IgM antibody measurement

2.11

1.55

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.43

1.53

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

332

1.42

1.51

1.4

13.23

12.83

u/l

0.17

319

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

533

4850

1.11

1.50

3.8

4.4

33.48

22.02

ug/l

0.31

443

3936

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

129

1054

1.23

1.49

1.4

1947.90

1104.13

e6/l

0.31

115

821

(40768441) Liver Pathology biopsy report

350

1.40

1.49

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

1.48

1.46

1.1

—

(3001729) Color of Synovial fluid

2.37

1.45

2.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

718

1.27

1.43

1.2

—

(3025130) Human papilloma virus identified in Specimen

637

0.72

1.43

1.9

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

117

951

1.24

1.43

1.7

1.4

10.68

16.09

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

171

1444

1.19

1.42

1.4

1.3

195.24

221.48

miu/ml

0.45

660

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

125

1024

1.23

1.42

2.6

3.8

210.66

822.76

u/ml

1.31

112

933

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

262

2290

1.15

1.42

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

117

952

1.23

1.42

1.7

1.4

—

(3035880) pH of Pleural fluid

262

1.45

1.40

1.4

1.3

7.44

7.40

0.53

182

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

165

1.58

1.40

2.8

1.8

418.86

24169.79

u/ml

—

(3013727) Leukocytes other/Leukocytes in Blood

126

1.67

1.39

6.5

4.0

50.57

55.35

0.39

121

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

524

4785

1.11

1.39

2.2

2.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.94

1.36

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.78

1.32

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.78

1.32

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.04

1.32

1.0

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1202

11393

1.07

1.32

3.2

2.4

—

(3037121) Protein [Mass/volume] in Urine

185

1586

1.17

1.31

3.6

3.1

640.61

358.24

mg/l

0.51

715

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

132

1579

0.83

1.31

1.7

5.52

3.86

mg/l

0.60

106

1158

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

340

3044

1.13

1.31

1.2

115.42

138.22

u/ml

0.58

120

1083

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.74

1.30

1.0

1.2

0.68

157.00

mg/l

1.26

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

420

1.34

1.30

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

326

1.38

1.29

1.1

262.71

279.55

mg/l

0.27

284

(3022493) Free Hemoglobin [Mass/volume] in Plasma

201

1.50

1.29

5.4

5.0

70.37

61.89

mg/l

0.26

142

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

159

1349

1.18

1.28

1.7

2.4

0.04

0.02

g/l

0.18

137

1214

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

137

1147

1.20

1.28

1.2

1.1

2.64

4.21

1.42

165

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

1.53

1.28

3.0

2.7

0.58

0.61

mmol/l

1.40

177

(3024928) Oxygen saturation in Venous blood

147

1239

1.19

1.28

5.2

3.1

63.21

61.60

0.39

137

1211

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.94

1.27

3.8

2.5

—

25.71

—

(3050129) First trimester maternal screen panel - Serum or Plasma

103

1257

0.82

1.26

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

313

2795

1.13

1.26

2.0

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

107

1.68

1.25

1.2

1.5

—

(3044927) Protein electrophoresis panel - Urine

449

1.32

1.25

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3678

37437

0.94

1.24

30.2

20.0

332.27

332.50

g/l

0.80

3653

37235

(40768800) Prostate Pathology biopsy report

1055

0.80

1.23

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.75

1.18

2.1

2.0

13.62

17.53

umol/l

0.85

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.93

1.17

1.0

1.1

—

(40768804) Tissue Pathology biopsy report

1882

18157

1.06

1.16

2.2

2.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

1.16

0.0

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

297

0.64

1.15

1.9

1.7

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4312

42582

1.07

1.15

21.5

15.4

81.90

81.43

ml/min/173m2

0.72

4091

39402

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

598

1.26

1.14

1.4

26.87

27.19

u/l

0.03

497

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

170

1469

1.16

1.13

1.6

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

267

1.39

1.12

1.3

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.12

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

432

1.30

1.11

1.2

1.3

—

titre

—

(3020650) Glucose [Presence] in Urine

160

1.50

1.09

1.5

1.8

0.00

0.04

estimate

0.80

160

(21494434) Karyotype in Bone marrow

407

1.31

1.09

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

104

866

1.20

1.07

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

104

866

1.20

1.07

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

151

1301

1.17

1.06

1.5

2.4

0.00

g/l

-0.00

121

1140

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

105

1.62

1.05

4.9

9.3

69.08

71.71

0.12

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.12

1.05

2.4

3.5

—

(3023410) Appearance of Cerebral spinal fluid

476

0.73

1.04

1.7

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

313

0.67

1.04

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.96

1.03

1.4

1.2

6.63

5.94

mmol/l

—

(4035726) Immunohistochemistry procedure

434

3995

1.09

1.03

1.5

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

221

1.41

1.02

1.3

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

221

1.41

1.02

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

221

1.41

1.02

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

221

1.41

1.02

1.3

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

1358

13027

1.06

1.02

3.6

2.8

0.20

0.06

0.71

321

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.92

1.02

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.92

1.02

1.0

1.1

7.09

8.60

u/ml

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

154

1335

1.16

1.01

3.3

2.6

194.56

194.53

0.00

146

1278

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

205

1.42

1.00

2.0

1.6

1.43

2.76

u/field

1.02

148

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.65

1.00

1.2

1.5

1.19

1.18

mmol/l

0.17

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

151

1309

1.16

0.99

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

257

2308

1.12

0.99

2.3

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

476

1.26

0.98

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

132

1.52

0.96

1.3

1.2

—

(4015189) Microbial culture of sputum

100

1.60

0.96

4.1

1.9

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

267

1.35

0.95

1.2

83.54

88.89

u/l

0.16

228

(3024932) HLA-DR beta [Type]

141

1.49

0.94

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.78

0.94

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

633

1.22

0.93

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

117

1.54

0.93

1.2

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.22

0.93

1.2

1.1

—

31.75

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

507

1.25

0.93

1.1

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.14

0.91

1.7

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

134

1.49

0.91

1.4

1.3

62.46

174.30

ug/l

0.73

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

167

1893

0.88

0.91

1.6

990.99

1011.01

mu/l

0.10

145

1576

(3008757) Leukocyte morphology finding [Identifier] in Blood

437

1.26

0.91

2.3

3.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

210

1.38

0.90

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

747

1.19

0.89

1.1

153.44

14466.98

iu/ml

0.53

162

(40761539) Cells [Type] in Urine sediment by Light microscopy

103

1.56

0.87

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

530

1.23

0.87

2.3

2.4

31.16

26.91

iu/ml

0.13

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.00

0.87

1.8

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

229

1.36

0.86

1.2

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1129

11763

0.95

0.86

5.4

4.2

86.80

88.95

2.11

1087

11532

(3020491) Glucose [Moles/volume] in Blood

345

0.72

0.85

2.2

1.7

7.93

6.60

mmol/l

1.45

239

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

170

1.41

0.85

1.2

1033.33

960.61

titre

—

(3019174) dRVVT (LA screen)

1.94

0.84

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.94

0.84

2.3

1.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.78

0.84

1.0

1.1

—

(3019225) pH of Specimen

457

4264

1.08

0.83

4.5

4.3

7.37

7.35

1.01

346

3067

(3028679) Herpes simplex virus Ab [Presence] in Serum

231

1.34

0.82

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.69

0.82

1.3

1.2

56.45

65.74

ug/l

1.01

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

699

0.81

0.82

1.5

0.18

0.40

nmol/l

4.66

543

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

572

1.21

0.80

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

306

0.72

0.80

1.1

16.32

19.96

u/ml

—

134

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.82

0.79

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.82

0.79

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

357

1.26

0.78

1.2

—

275.00

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

357

1.26

0.78

1.2

290.00

183.77

titre

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

375

1.26

0.78

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.59

0.78

1.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

394

1.25

0.76

1.3

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

305

1.28

0.76

1.3

1.5

—

(4146454) Self-monitoring of blood glucose

505

0.79

0.76

3.0

2.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

417

4460

0.93

0.75

3.1

2.4

39.91

50.51

u/l

0.46

362

3777

(3024471) HLA-A [Type]

141

1.42

0.74

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

210

1.34

0.73

1.1

1.2

11.18

9.53

mm/h

0.28

210

(3034092) Cytoplasmic Ig cells/cells in Blood

1.58

0.71

4.9

8.1

0.33

0.18

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.71

1.0

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.92

0.70

1.2

1.1

—

6.94

u/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.71

0.70

1.1

1.5

57.86

45.15

umol/l

—

(4133840) Spirometry

118

1.44

0.69

1.1

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.56

0.68

1.0

1.4

—

109.64

—

(3002523) Influenza virus A Ag [Presence] in Specimen

769

0.84

0.68

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

119

0.59

0.67

2.3

1.4

0.50

0.48

e9/l

—

119

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

205

1.32

0.67

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.54

0.67

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

767

0.85

0.66

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.53

0.66

1.0

10.80

36.47

iu/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

321

1.25

0.66

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

259

1.28

0.65

1.2

24.50

22.76

u/l

0.09

216

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.61

0.65

2.3

2.4

62.64

91.73

pmol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

968

0.87

0.64

4.0

3.3

26.90

26.70

mg/l

0.02

665

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

190

1731

1.10

0.64

2.7

3.7

541.28

2501.34

u/ml

0.69

168

1498

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

223

0.72

0.62

2.7

2.0

66.00

244.67

ug/min

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.52

0.62

1.5

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

342

1.23

0.62

2.0

2.96

1.70

u/field

0.89

181

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

461

1.20

0.61

4.1

3.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

1.42

0.61

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

471

1.19

0.61

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

703

1.15

0.60

1.3

1.2

1.87

3.59

u/ml

1.58

251

(3000034) Microalbumin [Mass/volume] in Urine

426

1.20

0.60

3.0

37.99

35.71

mg/l

0.04

314

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.59

0.0

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

254

1.26

0.59

1.4

1.2

0.53

0.62

ratio

1.50

145

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

10.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

106

1.42

0.57

1.8

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

328

1.22

0.57

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

137

1239

1.11

0.55

2.3

2.0

3.76

8.39

iu/l

0.51

515

(3044242) Glucose [Moles/volume] in Arterial blood

284

1.23

0.55

2.3

2.1

7.19

8.09

mmol/l

0.91

284

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.42

0.54

2.6

2.2

7.54

7.69

mmol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

609

1.15

0.53

1.1

1.31

2.98

—

107

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1643

16059

1.03

0.53

5.1

5.6

1.98

3.18

ug/l

4.12

1477

14563

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

178

1.29

0.52

1.7

1.8

40.92

40.35

g/l

0.18

178

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.50

0.51

1.7

2.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.51

2.4

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

781

1.13

0.51

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

225

1.25

0.49

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

225

1.25

0.49

1.1

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.49

0.47

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

598

1.14

0.46

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.38

0.46

1.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

296

2796

1.06

0.45

2.4

2.1

—

(4268621) Lupus anticoagulant assay

496

1.15

0.45

2.1

2.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

147

1.29

0.45

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

535

1.14

0.44

1.2

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

132

1212

1.09

0.43

1.9

206.93

203.91

pmol/l

0.14

123

1140

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1262

12913

0.97

0.42

4.6

4.5

22.54

21.97

0.62

612

6452

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.52

0.41

1.0

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

10412.40

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.4

—

1.35

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

132

1.29

0.40

1.5

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

433

0.85

0.40

4.7

3.5

10.15

12.63

index

2.27

256

(40757373) Influenza virus identified in Isolate

1.36

0.40

2.4

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.39

0.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

251

1.20

0.39

1.0

1.1

0.93

1.17

u/l

3.12

109

(3002256) Pathology report gross observation

608

6287

0.96

0.38

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

188

1.22

0.37

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

188

1.22

0.37

1.5

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.35

0.37

2.4

2.6

0.98

0.58

ug/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

801

1.10

0.36

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.29

0.36

2.0

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

139

1492

0.93

0.35

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.35

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

126

1.27

0.35

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.37

0.34

2.5

2.0

46.49

35.25

pmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.32

0.33

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

130

1212

1.07

0.33

1.5

2.5

0.00

g/l

-0.00

121

1140

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.28

0.32

1.0

1.3

2.00

1.68

umol/24h

—

(3050794) Legionella sp Ab [Presence] in Serum

1.28

0.32

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.33

0.32

2.0

1.9

2.58

1.95

ug/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

332

1.15

0.32

1.9

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

830

8105

1.03

0.31

3.5

3.0

1.28

1.13

e6/l

0.46

528

4304

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

343

1.14

0.30

1.4

1.2

80.00

82.28

—

(4211845) Urine protein measurement

218

0.83

0.30

3.5

3.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

399

0.88

0.29

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.25

0.29

3.4

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.23

0.29

1.1

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1329

13509

0.98

0.28

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

216

0.83

0.28

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1801

17781

1.02

0.27

3.8

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.25

0.27

1.1

1.2

49.88

71.38

ug/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

411

4243

0.97

0.27

2.4

2.3

12.35

13.10

nmol/l

1.17

364

3825

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.23

0.27

2.1

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.21

0.26

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

232

2222

1.05

0.26

3.1

3.7

68.40

63.58

u/ml

0.11

226

2145

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

104

1.25

0.26

1.1

1.2

887.38

297.81

pmol/l

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.68

0.26

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.68

0.26

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.68

0.26

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

141

1.21

0.26

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

1.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

1.2

1.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

114

1.23

0.25

1.1

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.20

0.25

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

217

1.15

0.24

1.5

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

161

1.18

0.24

1.2

1.9

—

(3005570) Glucose [Moles/volume] in Urine

447

1.10

0.23

3.2

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

119

1126

1.06

0.22

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

592

1.08

0.22

1.1

9.56

3.68

eliau/ml

0.51

277

(3006462) Nitrate [Presence] in Urine

200

0.85

0.22

3.5

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.22

0.22

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

868

1.06

0.20

1.2

1.3

27.62

31.68

u/l

0.19

754

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

684

1.07

0.19

1.3

1.2

2.41

5.17

u/ml

2.41

312

(37021550) Renin [Units/volume] in Plasma --upright

1.21

0.19

1.0

1.4

114.96

60.97

mu/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.18

0.19

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

109

1.19

0.18

1.8

1.6

0.51

0.41

ug/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

153

0.85

0.18

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.21

0.17

1.0

1.2

0.66

0.69

umol/24h

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

287

0.91

0.15

3.6

7.6

42.96

107.41

ug/l

0.51

190

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

151

0.86

0.15

5.2

2.9

5.04

4.84

kpa

0.33

151

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

151

0.86

0.15

5.2

2.9

11.75

10.29

kpa

0.73

151

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

442

0.93

0.15

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.77

0.15

1.3

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

217

1.11

0.14

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

305

1.08

0.13

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

200

1.10

0.12

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

508

0.94

0.12

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

444

1.06

0.11

1.2

—

(3049717) Cytology report of Urine Cyto stain

184

1794

1.03

0.11

2.8

2.7

—

(3022621) pH of Urine by Test strip

374

3678

1.02

0.11

3.4

2.6

6.05

6.07

0.11

257

2499

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

332

0.93

0.11

1.0

38.47

42.66

ng/l

0.21

234

(3006270) Folate [Moles/volume] in Blood

358

1.06

0.10

1.1

367.86

376.41

nmol/l

0.09

314

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

331

0.94

0.10

1.0

870.89

722.28

ng/l

0.84

230

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

320

0.94

0.09

1.1

6.79

9.40

iu/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

135

1.11

0.09

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.09

0.09

3.4

2.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

329

0.94

0.09

1.0

276.16

315.80

ng/l

0.44

236

(3001964) Herpes simplex virus Ag [Presence] in Specimen

117

1.11

0.08

2.3

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

195

1.08

0.08

2.7

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.08

0.07

1.4

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

235

1.06

0.07

4.6

3.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

237

1.06

0.05

6.7

6.4

46.20

12776.30

u/ml

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

344

0.96

0.05

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

346

1.04

0.05

1.3

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

151

0.93

0.05

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

333

0.96

0.05

1.3

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

434

0.97

0.05

2.7

5.8

406.13

48.48

u/ml

—

145

(3052851) Hemolysis interference index of Serum or Plasma

124

1259

0.98

0.04

3.6

3.4

1.96

2.08

index

0.06

663

(3014271) Vancomycin [Susceptibility]

209

1.05

0.04

3.2

2.7

—

(40768793) Breast Pathology biopsy report

996

0.98

0.04

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

321

0.97

0.03

1.3

1.1

—

(3034426) Prothrombin time (PT)

149

0.94

0.03

1.3

1.2

28.93

28.49

0.14

149

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

330

0.97

0.03

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

249

0.96

0.02

1.7

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

393

1.02

0.01

1.1

313.83

290.76

mg/l

0.58

358

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.03

0.00

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

318

1.01

0.00

1.3

165.53

194.14

pmol/l

0.40

318

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

748

1.00

0.00

1.1

28.63

16.76

au/ml

0.35

192

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

344

0.99

0.00

1.3

1.1

—

(3003129) Base excess in Capillary blood by calculation

546

1.01

0.00

2.6

2.3

0.09

0.64

mmol/l

0.55

532

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

359

1.00

0.00

1.3

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.17

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

8102.50

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

0.32

—

(3014891) Appearance of Pleural fluid

0.92

0.00

1.3

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

3150.00

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

41.48

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

410

1.00

-0.00

1.3

1.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.87

-0.00

1.0

98.07

75.81

ug/l

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

111

1110

1.00

-0.00

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

113

1130

1.00

-0.00

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_INFECT_DERM and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_INFECT_DERM	1.469 [1.34, 1.61]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.014

During the follow-up period (1.1.1998 — 31.12.2019), 2882 out of 16388 females with L12_INFECT_DERM died.

Males

Parameter	HR [95% CI]	p-value
L12_INFECT_DERM	1.857 [1.71, 2.02]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.05

During the follow-up period (1.1.1998 — 31.12.2019), 4766 out of 17856 males with L12_INFECT_DERM died.

Mortality risk

Mortality risk for people of age

years, who have L12_INFECT_DERM.

N-year risk	Females	Males
1	0.141%	0.336%
5	0.862%	2.178%
10	1.864%	6.076%
15	3.692%	11.038%
20	6.611%	18.34%

Relationships between endpoints

↥

Index endpoint: L12_INFECT_DERM – Infective dermatitis

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Infective dermatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints